{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 496599, "items": [{"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:35:12Z", "timestamp": 1575290112952}, "reference-count": 20, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2587, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 8]]}, "DOI": "10.1111/j.1399-3062.2007.00296.x", "type": "journal-article", "created": {"date-parts": [[2008, 7, 23]], "date-time": "2008-07-23T12:37:21Z", "timestamp": 1216816641000}, "page": "290-293", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation"], "prefix": "10.1111", "volume": "10", "author": [{"given": "S.", "family": "Neuburger", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "Massenkeil", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Seibold", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Lutz", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Tamm", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "le Coutre", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Graf", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Doerken", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Arnold", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1111/j.1399-3062.2007.00296.x-BIB1", "author": "Marr", "volume": "34", "first-page": "909", "year": "2002", "article-title": "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB2", "author": "Nucci", "volume": "98", "first-page": "315", "year": "2003", "article-title": "Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB3", "author": "Boutati", "volume": "90", "first-page": "999", "year": "1997", "article-title": "Fusarium, a significant emerging pathogen in patients with hematologic malignancy"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB4", "author": "Nucci", "volume": "38", "first-page": "1237", "year": "2004", "article-title": "Fusarium infection in hematopoietic stem cell transplant recipients"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB5", "author": "Arikan", "volume": "46", "first-page": "3084", "year": "2002", "article-title": "Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB6", "author": "Consigny", "volume": "37", "first-page": "311", "year": "2003", "article-title": "Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB7", "author": "Rodriguez", "volume": "31", "first-page": "411", "year": "2003", "article-title": "Successful treatment of disseminated fusariosis"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB8", "author": "Perfect", "volume": "36", "first-page": "1122", "year": "2003", "article-title": "Voriconazole treatment for less-common, emerging, or refractory fungal infections"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB9", "author": "Kontoyiannis", "volume": "45", "first-page": "139", "year": "2004", "article-title": "Outcome determinants of fusariosis in a tertiary care cancer center"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB10", "author": "Apostolidis", "volume": "36", "first-page": "1349", "year": "2003", "article-title": "Resolution of fungemia due to Fusarium species in a patients with acute leukaemia treated with caspofungin"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB11", "author": "Johnson", "volume": "36", "first-page": "225", "year": "2003", "article-title": "Voriconazole"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB12", "author": "Pfaller", "volume": "46", "first-page": "1032", "year": "2002", "article-title": "Antifungal activity of posaconazole, ravuconazole and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB13", "author": "Gupta", "volume": "9", "first-page": "156", "year": "2007"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB14", "author": "Raad", "volume": "42", "first-page": "1398", "year": "2006", "article-title": "Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB15", "author": "Herbrecht", "volume": "23", "first-page": "1451", "year": "2004", "article-title": "Successful treatment of Fusarium proliferatum with posaconazole in a lung transplant recipient"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB16", "author": "Reuben", "volume": "33", "first-page": "1647", "year": "1989"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB17", "author": "Rotowa", "volume": "33", "first-page": "203", "year": "1990", "article-title": "In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB18", "author": "Rothe", "volume": "83", "first-page": "394", "year": "2004", "article-title": "Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB19", "author": "Nedelman", "volume": "36", "first-page": "452", "year": "1996", "article-title": "Pharmacokinetics and pharmacodynamics of multiple-dose terbinafine"}, {"key": "10.1111/j.1399-3062.2007.00296.x-BIB20", "author": "Schmitt", "volume": "9", "first-page": "832", "year": "1990", "article-title": "Inactivity of terbinafine in a rat model of pulmonary aspergillosis"}], "container-title": ["Transplant Infectious Disease"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-3062.2007.00296.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 3, 31]], "date-time": "2017-03-31T09:55:11Z", "timestamp": 1490954111000}, "score": 85.01529, "issued": {"date-parts": [[2008, 8]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2008, 8]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/j.1399-3062.2007.00296.x", "relation": {"cites": []}, "ISSN": ["1398-2273", "1399-3062"], "issn-type": [{"value": "1398-2273", "type": "print"}, {"value": "1399-3062", "type": "electronic"}], "subject": ["Transplantation", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T18:51:11Z", "timestamp": 1574189471999}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 12, 1]], "date-time": "2006-12-01T00:00:00Z", "timestamp": 1164931200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Infection"], "published-print": {"date-parts": [[2006, 12]]}, "DOI": "10.1016/j.jinf.2006.02.011", "type": "journal-article", "created": {"date-parts": [[2006, 4, 12]], "date-time": "2006-04-12T19:28:28Z", "timestamp": 1144870108000}, "page": "e243-e246", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B"], "prefix": "10.1016", "volume": "53", "author": [{"given": "M", "family": "STANZANI", "sequence": "first", "affiliation": []}, {"given": "N", "family": "VIANELLI", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "BANDINI", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "PAOLINI", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "ARPINATI", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "BONIFAZI", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "GIANNINI", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "AGOSTINELLI", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "BACCARANI", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "RICCI", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Infection"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S016344530600065X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S016344530600065X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 17]], "date-time": "2019-01-17T05:27:30Z", "timestamp": 1547702850000}, "score": 59.04485, "issued": {"date-parts": [[2006, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 12]]}, "issue": "6"}, "alternative-id": ["S016344530600065X"], "URL": "http://dx.doi.org/10.1016/j.jinf.2006.02.011", "ISSN": ["0163-4453"], "issn-type": [{"value": "0163-4453", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T23:06:36Z", "timestamp": 1574291196290}, "reference-count": 16, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3014, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transplant Infect Dis"], "published-print": {"date-parts": [[2007, 6]]}, "DOI": "10.1111/j.1399-3062.2006.00189.x", "type": "journal-article", "created": {"date-parts": [[2007, 5, 6]], "date-time": "2007-05-06T17:05:02Z", "timestamp": 1178471102000}, "page": "156-160", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation"], "prefix": "10.1111", "volume": "9", "author": [{"given": "S.", "family": "Gupta", "sequence": "first", "affiliation": []}, {"given": "N.G.", "family": "Almyroudis", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Battiwalla", "sequence": "additional", "affiliation": []}, {"given": "B.J.", "family": "Bambach", "sequence": "additional", "affiliation": []}, {"given": "P.L.", "family": "McCarthy", "sequence": "additional", "affiliation": []}, {"given": "A.D.", "family": "Proefrock", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Ball", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Paplham", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Varma", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Kwon-Chung", "sequence": "additional", "affiliation": []}, {"given": "B.H.", "family": "Segal", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_288", "author": "Kontoyiannis DP", "volume": "45", "first-page": "139", "year": "2004", "journal-title": "Leuk Lymphoma", "DOI": "10.1080/1042819031000149386", "doi-asserted-by": "crossref"}, {"key": "b2_289", "author": "Boutati EI", "volume": "90", "first-page": "999", "year": "1997", "journal-title": "Blood"}, {"key": "b3_290", "DOI": "10.1086/339202", "doi-asserted-by": "publisher"}, {"key": "b4_291", "author": "Nucci M", "volume": "38", "first-page": "1237", "year": "2004", "journal-title": "Clin Infect Dis", "DOI": "10.1086/383319", "doi-asserted-by": "crossref"}, {"key": "b5_292", "author": "Lozano-Chiu M", "volume": "43", "first-page": "589", "year": "1999", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.43.3.589", "doi-asserted-by": "crossref"}, {"key": "b6_293", "author": "Herbrecht R", "volume": "23", "first-page": "1451", "year": "2004", "journal-title": "J Heart Lung Transplant", "DOI": "10.1016/j.healun.2003.09.033", "doi-asserted-by": "crossref"}, {"key": "b7_294", "author": "Raad II", "volume": "46", "first-page": "1398", "year": "2006", "journal-title": "Clin Infect Dis", "DOI": "10.1086/503425", "doi-asserted-by": "crossref"}, {"key": "b8_295", "unstructured": "8. I Raad, S Chapman, and R Bradsher , et al. Posaconazole (POS) salvage therapy for invasive fungal infections. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. 2004, Washington, DC (Abstract M-669)."}, {"key": "b9_296", "DOI": "10.1016/S1473-3099(05)70297-8", "doi-asserted-by": "publisher"}, {"key": "b10_297", "DOI": "10.1086/430068", "doi-asserted-by": "publisher"}, {"key": "b11_298", "author": "Woloshuk CP", "volume": "61", "first-page": "3019", "year": "1995", "journal-title": "Appl Environ Microbiol"}, {"key": "b12_299", "author": "Hue FX", "volume": "37", "first-page": "2434", "year": "1999", "journal-title": "J Clin Microbiol"}, {"key": "b13_300", "DOI": "10.1128/AAC.46.10.3298-3300.2002", "doi-asserted-by": "publisher"}, {"key": "b14_301", "unstructured": "14. AJ Ullmann, JH Lipton, and DH Vesole , et al. Posaconazole (POS) vs. fluconazole (FLU) for prophylaxis for invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): results of a multicenter trial. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005, Washington, DC (Abstract M-716)."}, {"key": "b15_302", "unstructured": "15. OA Cornely, J Maertens, and DJ Winston , et al. Posaconazole (POS) vs standard azoles as antifungal prophylaxis in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS): impact on mortality. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005, Washington, DC (Abstract 722-b)."}, {"key": "b16_303", "author": "Segal BH", "volume": "173", "first-page": "707", "year": "2006", "journal-title": "Am J Respir Crit Care Med", "DOI": "10.1164/rccm.200505-727SO", "doi-asserted-by": "crossref"}], "container-title": ["Transplant Infectious Disease"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-3062.2006.00189.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 30]], "date-time": "2019-01-30T00:20:13Z", "timestamp": 1548807613000}, "score": 41.900352, "issued": {"date-parts": [[2007, 6]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2007, 6]]}, "issue": "2"}, "alternative-id": ["10.1111/j.1399-3062.2006.00189.x"], "URL": "http://dx.doi.org/10.1111/j.1399-3062.2006.00189.x", "relation": {"cites": []}, "ISSN": ["1398-2273", "1399-3062"], "issn-type": [{"value": "1398-2273", "type": "print"}, {"value": "1399-3062", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T19:43:56Z", "timestamp": 1575315836676}, "publisher-location": "Boston, MA", "reference-count": 185, "publisher": "Springer US", "isbn-type": [{"value": "9780387785790", "type": "print"}, {"value": "9780387785806", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-0-387-78580-6_20", "type": "book-chapter", "created": {"date-parts": [[2008, 10, 23]], "date-time": "2008-10-23T14:57:52Z", "timestamp": 1224773872000}, "page": "497-537", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Cellular Adoptive Immunotherapy After Autologous and Allogeneic Hematopoietic Stem Cell Transplantation"], "prefix": "10.1007", "author": [{"given": "David L.", "family": "Porter", "sequence": "first", "affiliation": []}, {"given": "Elizabeth O.", "family": "Hexner", "sequence": "additional", "affiliation": []}, {"given": "Sarah", "family": "Cooley", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey S.", "family": "Miller", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 10, 31]]}, "reference": [{"key": "20_CR1", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1111/j.1365-2141.1957.tb05793.x", "volume": "3", "author": "D. Barnes", "year": "1957", "unstructured": "Barnes D, Loutit J. Treatment of murine leukaemia with x-rays and homologous bone marrow. Br J Haematol. 1957;3:241\u201352.", "journal-title": "Br J Haematol."}, {"key": "20_CR2", "first-page": "555", "volume": "75", "author": "M. Horowitz", "year": "1990", "unstructured": "Horowitz M, Gale R, Sondel P, Goldman J, Dersey J, Kolb H, Rimm A, Ringden O, Rozman C, Speck B, Truitt R, Zwaan F, Bortin M. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555\u201362.", "journal-title": "Blood"}, {"key": "20_CR3", "first-page": "2462", "volume": "76", "author": "H. Kolb", "year": "1990", "unstructured": "Kolb H, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462\u20135.", "journal-title": "Blood"}, {"key": "20_CR4", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1056/NEJM199401133300204", "volume": "330", "author": "D. Porter", "year": "1994", "unstructured": "Porter D, Roth M, McGarigle C, Ferrara J, Antin J. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med. 1994;330:100\u20136.", "journal-title": "N Engl J Med."}, {"key": "20_CR5", "doi-asserted-by": "crossref", "first-page": "927", "DOI": "10.1038/sj.bmt.1700762", "volume": "19", "author": "A. Bacigalupo", "year": "1997", "unstructured": "Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F, Lamparelli T, Occhini D, Mordini N, Bregante S, Figari O, Benvenuto F, Sessarego M, Fugazza G, Carlier P, Valbonesi M. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19:927\u201332.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR6", "first-page": "2041", "volume": "86", "author": "H. Kolb", "year": "1995", "unstructured": "Kolb H, Schattenberg A, Goldman J, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:2041\u201350.", "journal-title": "Blood"}, {"key": "20_CR7", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1200/JCO.1997.15.2.433", "volume": "15", "author": "R. Collins", "year": "1997", "unstructured": "Collins R, Shpilberg O, Drobyski W, Porter D, Giralt S, Champlin R, Goodman S, Wolff S, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin J, Nemunaitis J. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433\u201344.", "journal-title": "J Clin Oncol."}, {"key": "20_CR8", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1200/JCO.2002.20.2.405", "volume": "20", "author": "J. Levine", "year": "2002", "unstructured": "Levine J, Braun T, Penza S, Beatty P, Cornetta K, Martino R, Drobyski W, Barrett A, Porter D, Giralt S, Horowitz M, Leis J, Johnson M, Collins R. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem cell transplantation. J Clin Oncol. 2002;20:405\u201312.", "journal-title": "J Clin Oncol."}, {"key": "20_CR9", "doi-asserted-by": "crossref", "first-page": "4938", "DOI": "10.1200/JCO.2007.11.6053", "volume": "25", "author": "C. Schmid", "year": "2007", "unstructured": "Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, Volin L, Gurman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol. 2007;25:4938\u201345.", "journal-title": "J Clin Oncol."}, {"key": "20_CR10", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1038/sj.leu.2403523", "volume": "18", "author": "SJ. Choi", "year": "2004", "unstructured": "Choi SJ, Lee JH, Kim S, Seol M, Lee YS, Lee JS, Kim WK, Chi HS, Lee KH. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia 2004;18:1789\u201397.", "journal-title": "Leukemia"}, {"key": "20_CR11", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1038/sj.bmt.1702555", "volume": "26", "author": "RH. Collins", "year": "2000", "unstructured": "Collins RH Jr, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W, Barrett J, Johnson M, Kirk A, Horowitz M, Parker P. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant. 2000;26:511\u201316.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR12", "doi-asserted-by": "crossref", "first-page": "965", "DOI": "10.1038/sj.bmt.1705840", "volume": "40", "author": "PV. Campregher", "year": "2007", "unstructured": "Campregher PV, Gooley T, Scott BL, Moravec C, Sandmaier B, Martin PJ, Deeg HJ, Warren EH, Flowers ME. Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation. Bone Marrow Transplant. 2007;40:965\u201371.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR13", "first-page": "4206", "volume": "90", "author": "HM. Lokhorst", "year": "1997", "unstructured": "Lokhorst HM, Schattenberg A, Cornelissen JJ, Thomas LL, Verdonck LF. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood 1997;90:4206\u201311.", "journal-title": "Blood"}, {"key": "20_CR14", "doi-asserted-by": "crossref", "first-page": "3031", "DOI": "10.1200/JCO.2000.18.16.3031", "volume": "18", "author": "HM. Lokhorst", "year": "2000", "unstructured": "Lokhorst HM, Schattenberg A, Cornelissen JJ, van Oers MH, Fibbe W, Russell I, Donk NW, Verdonck LF. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. J Clin Oncol. 2000;18:3031\u20137.", "journal-title": "J Clin Oncol."}, {"key": "20_CR15", "doi-asserted-by": "crossref", "first-page": "1179", "DOI": "10.1038/sj.bmt.1702685", "volume": "26", "author": "M. Salama", "year": "2000", "unstructured": "Salama M, Nevill T, Marcellus D, Parker P, Johnson M, Kirk A, Porter D, Giralt S, Levine J, Drobyski W, Barrett A, Horowitz M, Collins R. Donor leukocyte infusions for multiple myeloma. Bone Marrow Transplant. 2000;26:1179\u201384.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR16", "first-page": "549a", "volume": "90", "author": "D. Porter", "year": "1997", "unstructured": "Porter D, Collins R, Drobyski W, Connors J, Van Hoef M, Antin J. Long-term follow-up of 55 patients who achieved complete remission (CR) after donor leukocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT). Blood 1997;90:549a.", "journal-title": "Blood"}, {"key": "20_CR17", "first-page": "2712", "volume": "96", "author": "F. Dazzi", "year": "2000", "unstructured": "Dazzi F, Szydlo RM, Cross NC, Craddock C, Kaeda J, Kanfer E, Cwynarski K, Olavarria E, Yong A, Apperley JF, Goldman JM. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2000;96:2712\u20136.", "journal-title": "Blood"}, {"key": "20_CR18", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1053/bbmt.1999.v5.pm10465105", "volume": "5", "author": "D. Porter", "year": "1999", "unstructured": "Porter D, Collins R, Shpilberg O, Drobyski W, Connors J, Sproles A, Antin J. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biol Blood Marrow Transplant. 1999;5:253\u201361.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR19", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1053/bbmt.2001.v7.pm11215696", "volume": "7", "author": "S. Carlens", "year": "2001", "unstructured": "Carlens S, Remberger M, Aschan J, Ringden O. The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse. Biol Blood Marrow Transplant. 2001;7:31\u20138.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR20", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.7326/0003-4819-120-8-199404150-00004", "volume": "120", "author": "R. Gale", "year": "1994", "unstructured": "Gale R, Horowitz M, Ash R, Champlin R, Goldman J, Rimm A, Ringden O, Veum Stone J, Bortin M. Identical-twin bone marrow transplants for leukemia. Ann Intern Med. 1994;120:646\u201352.", "journal-title": "Ann Intern Med."}, {"key": "20_CR21", "first-page": "975", "volume": "18", "author": "D. Porter", "year": "1996", "unstructured": "Porter D, Roth M, Lee S, McGarigle C, Ferrara J, Antin J. Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;18:975\u201380.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR22", "first-page": "109", "volume": "11", "author": "J. Szer", "year": "1993", "unstructured": "Szer J, Grigg A, Phillipos G, Sheridan W. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT. Bone Marrow Transplant. 1993;11:109\u201311.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR23", "doi-asserted-by": "crossref", "first-page": "1754", "DOI": "10.1080/10428190600632857", "volume": "47", "author": "I. Cunningham", "year": "2007", "unstructured": "Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma. 2007;47:1754\u201367.", "journal-title": "Leuk Lymphoma."}, {"key": "20_CR24", "unstructured": "Chong G, Byrnes G, Szer J, Grigg A. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant. 1011;26:1011\u20135.", "DOI": "10.1038/sj.bmt.1702659", "doi-asserted-by": "crossref"}, {"key": "20_CR25", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.3109/10428199509056823", "volume": "17", "author": "D. Porter", "year": "1995", "unstructured": "Porter D, Antin J. Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation. Leuk Lymphoma. 1995;17:191\u20137.", "journal-title": "Leuk Lymphoma."}, {"key": "20_CR26", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1038/sj.bmt.1704381", "volume": "33", "author": "S. Depil", "year": "2004", "unstructured": "Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet JP, Damaj G, Yakoub-Agha I, Societe Francaise de Greffe de Moelle et Therapie c. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant. 2004;33:531\u20134.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR27", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1089/152581602753658457", "volume": "11", "author": "S. Slavin", "year": "2002", "unstructured": "Slavin S, Morecki S, Weiss L, Or R. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation. J Hematother Stem Cell Res. 2002;11:265\u201376.", "journal-title": "J Hematother Stem Cell Res."}, {"key": "20_CR28", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1038/sj.bmt.1705024", "volume": "36", "author": "SJ. Choi", "year": "2005", "unstructured": "Choi SJ, Lee JH, Kim S, Lee YS, Seol M, Ryu SG, Lee JS, Kim WK, Jang S, Park CJ, Chi HS, Lee KH. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study. Bone Marrow Transplant. 2005;36:163\u20139.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR29", "first-page": "4711", "volume": "88", "author": "BB. Bjorkstrand", "year": "1996", "unstructured": "Bjorkstrand BB, Ljungman P, Svensson H, Hermans J, Alegre A, Apperley J, Blade J, Carlson K, Cavo M, Ferrant A, Goldstone AH, de Laurenzi A, Majolino I, Marcus R, Prentice HG, Remes K, Samson D, Sureda A, Verdonck LF, Volin L, Gahrton G. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 1996;88:4711\u20138.", "journal-title": "Blood"}, {"key": "20_CR30", "doi-asserted-by": "crossref", "first-page": "2574", "DOI": "10.1182/blood.V97.9.2574", "volume": "97", "author": "A. Badros", "year": "2001", "unstructured": "Badros A, Barlogie B, Morris C, Desikan R, Martin SR, Munshi N, Zangari M, Mehta J, Toor A, Cottler-Fox M, Fassas A, Anaissie E, Schichman S, Tricot G, Aniassie E. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions. Blood 2001;97:2574\u20139.", "journal-title": "Blood"}, {"key": "20_CR31", "doi-asserted-by": "crossref", "first-page": "1110", "DOI": "10.1056/NEJMoa065464", "volume": "356", "author": "B. Bruno", "year": "2007", "unstructured": "Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Giaccone L, Sorasio R, Omede P, Baldi I, Bringhen S, Massaia M, Aglietta M, Levis A, Gallamini A, Fanin R, Palumbo A, Storb R, Ciccone G, Boccadoro M. A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med. 2007;356:1110\u201320.", "journal-title": "N Engl J Med."}, {"key": "20_CR32", "first-page": "1196", "volume": "87", "author": "G. Tricot", "year": "1996", "unstructured": "Tricot G, Vesole D, Jagannath S, Hilton J, Munshi N, Barlogie B. Graft-versus-myeloma effect: proof of principle. Blood 1996;87:1196\u20138.", "journal-title": "Blood"}, {"key": "20_CR33", "doi-asserted-by": "crossref", "first-page": "3361", "DOI": "10.1182/blood-2004-05-2031", "volume": "104", "author": "N. Kroger", "year": "2004", "unstructured": "Kroger N, Shimoni A, Zagrivnaja M, Ayuk F, Lioznov M, Schieder H, Renges H, Fehse B, Zabelina T, Nagler A, Zander AR. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma. Blood 2004;104:3361\u20133.", "journal-title": "Blood"}, {"key": "20_CR34", "first-page": "1050", "volume": "84", "author": "V. Ratanatharathorn", "year": "1994", "unstructured": "Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F, Cummings G, Sensenbrenner LL. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma. Blood 1994;84:1050\u20135.", "journal-title": "Blood"}, {"key": "20_CR35", "first-page": "649", "volume": "77", "author": "R. Jones", "year": "1991", "unstructured": "Jones R, Ambinder R, Piantadosi S, Santos G. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991;77:649\u201353.", "journal-title": "Blood"}, {"key": "20_CR36", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1038/sj.bmt.1701587", "volume": "23", "author": "M. Bernard", "year": "1999", "unstructured": "Bernard M, Dauriac C, Drenou B, Leberre C, Branger B, Fauchet R, Le Prise PY, Lamy T. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin\u2019s lymphoma. Bone Marrow Transplant. 1999;23:329\u201333.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR37", "doi-asserted-by": "crossref", "first-page": "4310", "DOI": "10.1182/blood-2001-11-0107", "volume": "100", "author": "S. Robinson", "year": "2002", "unstructured": "Robinson S, Goldstone AH, Mackinnon S, Carella A, Russell N, DeElvira R, Taghipour G, Schmitz N. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood 2002;100:4310\u20136.", "journal-title": "Blood"}, {"key": "20_CR38", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1038/sj.bmt.1703895", "volume": "31", "author": "D. Porter", "year": "2003", "unstructured": "Porter D, Stadtmauer EA, Lazarus H. \u201cGVHD\u201d: graft-versus host disease or graft-versus Hodgkin\u2019s disease? An old acronym with new meaning. Bone Marrow Transplant. 2003;31:739\u201346.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR39", "doi-asserted-by": "crossref", "first-page": "1934", "DOI": "10.1016/S0140-6736(05)66659-7", "volume": "365", "author": "KS. Peggs", "year": "2005", "unstructured": "Peggs KS, Hunter A, Chopra R, Parker A, Mahendra P, Milligan D, Craddock C, Pettengell R, Dogan A, Thomson KJ, Morris EC, Hale G, Waldmann H, Goldstone AH, Linch DC, Mackinnon S. Clinical evidence of a graft-versus-Hodgkin\u2019s-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet 2005;365:1934\u201341.", "journal-title": "Lancet"}, {"key": "20_CR40", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/j.bbmt.2005.09.009", "volume": "12", "author": "I. Alvarez", "year": "2006", "unstructured": "Alvarez I, Sureda A, Caballero MD, Urbano-Ispizua A, Ribera JM, Canales M, Garcia-Conde J, Sanz G, Arranz R, Bernal MT, de la Serna J, Diez JL, Moraleda JM, Rubio-Felix D, Xicoy B, Martinez C, Mateos MV, Sierra J. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: results of a Spanish prospective cooperative protocol. Biol Blood Marrow Transplant. 2006;12:172\u201383.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR41", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1016/j.bbmt.2006.03.013", "volume": "12", "author": "P. Anderlini", "year": "2006", "unstructured": "Anderlini P, Champlin RE. Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand? Biol Blood Marrow Transplant. 2006;12:599\u2013602.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR42", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1097/01.cco.0000208781.61452.d3", "volume": "18", "author": "A. Loren", "year": "2006", "unstructured": "Loren A, Porter D. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation. Curr Opin Oncol. 2006;18:107\u201314.", "journal-title": "Curr Opin Oncol."}, {"key": "20_CR43", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1038/sj.bmt.1701224", "volume": "21", "author": "R. Rhee van", "year": "1998", "unstructured": "van Rhee R, Savage D, Blackwell J, Orchard K, Dazzi F, Lin F, Chase A, Bungey J, Cross N, Apperley J, Szydlo R, Goldman J. Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors. Bone Marrow Transplant. 1998;21:1055\u201361.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR44", "first-page": "1214", "volume": "95", "author": "D. Porter", "year": "2000", "unstructured": "Porter D, Collins R, Hardy C, Kernan N, Drobyski W, Giralt S, Flowers M, Casper J, Leahey A, Parker P, Mick R, Bate-Boyle B, King R, Antin J. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000;95:1214\u201321.", "journal-title": "Blood"}, {"key": "20_CR45", "author": "D. Porter", "first-page": "733", "year": "1997", "unstructured": "Porter D, Antin J. Adoptive immunotherapy in bone marrow transplantation. In: Burakoff S, Deeg H, Ferrara J, editors. Graft-versus-host disease. New York: Marcel Dekker; 1997. p. 733\u201354.", "volume-title": "Graft-versus-host disease"}, {"key": "20_CR46", "first-page": "1261", "volume": "86", "author": "S. Mackinnon", "year": "1995", "unstructured": "Mackinnon S, Papadopoulos E, Carabasi M, Reich L, Collins N, Boulad F, Castro-Malaspina H, Childs B, Gillio A, Kernan N, Small T, Young J, O\u2019Reilly R. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995;86:1261\u20138.", "journal-title": "Blood"}, {"key": "20_CR47", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1053/j.seminhematol.2005.09.005", "volume": "43", "author": "D. Porter", "year": "2007", "unstructured": "Porter D, Levine J. GVHD and GVL after donor leukocyte infusion. Semin Hematol. 2007;43:53\u201361.", "journal-title": "Semin Hematol."}, {"key": "20_CR48", "author": "D. Porter", "first-page": "57", "year": "1997", "unstructured": "Porter D, Antin J. Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions. In: Winter J, editor. Blood stem cell transplantation. Norwell: Kluwer Academic Publishers; 1997. p. 57\u201386.", "volume-title": "Blood stem cell transplantation", "DOI": "10.1007/978-1-4615-6349-5_3", "doi-asserted-by": "crossref"}, {"key": "20_CR49", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1016/j.bbmt.2003.10.004", "volume": "10", "author": "EG. Chiorean", "year": "2004", "unstructured": "Chiorean EG, DeFor TE, Weisdorf DJ, Blazar BR, McGlave PB, Burns LJ, Brown C, Miller JS. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2004;10:171\u20137.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR50", "first-page": "3113", "volume": "89", "author": "F. Keil", "year": "1997", "unstructured": "Keil F, Haas OA, Fritsch G, Kalhs P, Lechner K, Mannhalter C, Reiter E, Niederwieser D, Hoecker P, Greinix HT. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. Blood 1997;89:3113\u20137.", "journal-title": "Blood"}, {"key": "20_CR51", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1016/S1083-8791(00)70057-7", "volume": "6", "author": "M. Flowers", "year": "2000", "unstructured": "Flowers M, Leisenring W, Beach K, Riddell S, Radich J, Higano C, Rowley S, Chauncey T, Bensinger W, Sanders J, Anasetti C, Storb R, Wade J, Appelbaum F, Martin P. Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation. Biol Blood Marrow Transplant. 2000;6:321\u20136.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR52", "first-page": "807", "volume": "95", "author": "A. Gustafsson", "year": "2000", "unstructured": "Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 2000;95:807\u201314.", "journal-title": "Blood"}, {"key": "20_CR53", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1038/sj.bmt.1703806", "volume": "31", "author": "AW. Loren", "year": "2003", "unstructured": "Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant. 2003;31:145\u201355.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR54", "first-page": "1234", "volume": "71", "author": "R. Shapiro", "year": "1988", "unstructured": "Shapiro R, McClain K, Frizzera G, Gajl-Peczalska K, Kersey J, Blazar B, Arthur D, Patton D, Greenberg J, Burke B, Ramsay N, McGlave P, Filipovich A. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988;71:1234\u201343.", "journal-title": "Blood"}, {"key": "20_CR55", "first-page": "11", "volume": "4", "author": "D. Porter", "year": "1994", "unstructured": "Porter D, Orloff G, Antin J. Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant. Transplant Sci. 1994;4:11\u201315.", "journal-title": "Transplant Sci."}, {"key": "20_CR56", "doi-asserted-by": "crossref", "first-page": "1185", "DOI": "10.1056/NEJM199404283301703", "volume": "330", "author": "E. Papadopoulos", "year": "1994", "unstructured": "Papadopoulos E, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi M, Castro-Malaspina J, Childs B, Gillio A, Small T, Young J, Kernan N, O\u2019Reilly R. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med. 1994;330:1185\u201391.", "journal-title": "N Engl J Med."}, {"key": "20_CR57", "first-page": "1549", "volume": "92", "author": "C. Rooney", "year": "1998", "unstructured": "Rooney C, Smith C, Ng C, Loftin S, Sixbey J, Gan Y, Srivastava DK, Bowman L, Krance R, Brenner M, Heslop H. Infusion of cytoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998;92:1549\u201355.", "journal-title": "Blood"}, {"key": "20_CR58", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1126/science.1352912", "volume": "257", "author": "S. Riddell", "year": "1992", "unstructured": "Riddell S, Watanabe K, Goodrich J, Li C, Agha M, Greenberg P. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 1992;257:238\u201341.", "journal-title": "Science"}, {"key": "20_CR59", "doi-asserted-by": "crossref", "first-page": "1038", "DOI": "10.1056/NEJM199510193331603", "volume": "333", "author": "E. Walter", "year": "1995", "unstructured": "Walter E, Greenberg P, Gilbert M, Finch R, Watanabe K, Thomas E, Riddell S. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038\u201344.", "journal-title": "N Engl J Med."}, {"key": "20_CR60", "first-page": "1690", "volume": "84", "author": "R. Hromas", "year": "1994", "unstructured": "Hromas R, Cornetta K, Srour E. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994;84(5):1689\u201390.", "journal-title": "Blood"}, {"key": "20_CR61", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1038/sj.bmt.1702559", "volume": "26", "author": "Y. Kishi", "year": "2000", "unstructured": "Kishi Y, Kami M, Oki Y, Kazuyama Y, Kawabata M, Miyakoshi S, Morinaga S, Suzuki R, Mori S, Muto Y. Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant. 2000;26:573\u20136.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR62", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1182/blood.V100.2.397", "volume": "100", "author": "C. Guglielmi", "year": "2002", "unstructured": "Guglielmi C, Arcese W, Dazzi F, Brand R, Bunjes D, Verdonck LF, Schattenberg A, Kolb HJ, Ljungman P, Devergie A, Bacigalupo A, Gomez M, Michallet M, Elmaagacli A, Gratwohl A, Apperley J, Niederwieser D. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 2002;100:397\u2013405.", "journal-title": "Blood"}, {"key": "20_CR63", "first-page": "1720", "volume": "73", "author": "K. Sullivan", "year": "1989", "unstructured": "Sullivan K, Weiden P, Storb R, Witherspoon R, Fefer A, Fisher L, Buckner C, Anasetti C, Appelbaum F, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever M, Clift R, Deeg H, Doney K, Greenberg P, Hansen J, Hill R, Loughran T, Martin P, Neiman P, Peterson F, Sanders J, Singer J, Stewart P, Thomas E. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989;73:1720\u20138.", "journal-title": "Blood"}, {"key": "20_CR64", "first-page": "329", "volume": "11", "author": "B. Johnson", "year": "1993", "unstructured": "Johnson B, Drobyski W, Truitt R. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant. 1993;11:329\u201336.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR65", "first-page": "1212", "volume": "116", "author": "P. Weiden", "year": "1978", "unstructured": "Weiden P, Storb R, Tsoi M, Graham T, Lerner K, Thomas E. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. J Immunol. 1978;116:1212\u20139.", "journal-title": "J Immunol."}, {"key": "20_CR66", "first-page": "3671", "volume": "91", "author": "E. Alyea", "year": "1998", "unstructured": "Alyea E, Soiffer R, Canning C, Neuberg D, Schlossman R, Pickett C, Collins H, Wang Y, Anderson K, Ritz J. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998;91:3671\u201380.", "journal-title": "Blood"}, {"key": "20_CR67", "first-page": "4337", "volume": "86", "author": "S. Giralt", "year": "1995", "unstructured": "Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, Van Besien K, Khouri I, Mehra R, Przepiorka D, Korbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 1995;86:4337\u201343.", "journal-title": "Blood"}, {"key": "20_CR68", "doi-asserted-by": "crossref", "first-page": "568", "DOI": "10.1016/S1083-8791(01)70017-1", "volume": "7", "author": "A. Shimoni", "year": "2001", "unstructured": "Shimoni A, Gajewski J, Donato M, Martin T, O\u2019Brien S, Talpaz M, Cohen A, Korbling M, Champlin R, Giralt S. Long-term follow-up of recipients of CD8 depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant. 2001;7:568\u201375.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR69", "first-page": "3222", "volume": "94", "author": "EK. Waller", "year": "1999", "unstructured": "Waller EK, Ship AM, Mittelstaedt S, Murray TW, Carter R, Kakhniashvili I, Lonial S, Holden JT, Boyer MW. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Blood 1999;94:3222\u201333.", "journal-title": "Blood"}, {"key": "20_CR70", "first-page": "5145", "volume": "163", "author": "RL. Truitt", "year": "1999", "unstructured": "Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE. Photochemical treatment with S-59 psoralen and ultraviolet: a light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. J Immunol. 1999;163:5145\u201356.", "journal-title": "J Immunol."}, {"key": "20_CR71", "first-page": "214a", "volume": "82", "author": "P. Servida", "year": "1993", "unstructured": "Servida P, Rossini S, Traversari C, Ferrari G, Bonini C, Nobili N, Vago L, Faravelli A, Vanzulli A, Mavillio F, Bordignon C. Gene transfer into peripheral blood lymphocytes for in vivo immunomodulation of donor anti-tumor immunity in a patient affected by EBV-induced lymphoma. Blood 1993;82:214a.", "journal-title": "Blood"}, {"key": "20_CR72", "doi-asserted-by": "crossref", "first-page": "1719", "DOI": "10.1126/science.276.5319.1719", "volume": "276", "author": "C. Bonini", "year": "1997", "unstructured": "Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997;276:1719\u201324.", "journal-title": "Science"}, {"key": "20_CR73", "first-page": "1201", "volume": "94", "author": "JH. Falkenburg", "year": "1999", "unstructured": "Falkenburg JH, Wafelman AR, Joosten P, Smit WM, van Bergen CA, Bongaerts R, Lurvink E, van der Hoorn M, Kluck P, Landegent JE, Kluin-Nelemans HC, Fibbe WE, Willemze R. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 1999;94:1201\u20138.", "journal-title": "Blood"}, {"key": "20_CR74", "first-page": "549", "volume": "90", "author": "AA. Cardoso", "year": "1997", "unstructured": "Cardoso AA, Seamon MJ, Afonso HM, Ghia P, Boussiotis VA, Freeman GJ, Gribben JG, Sallan SE, Nadler LM. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood 1997;90:549\u201361.", "journal-title": "Blood"}, {"key": "20_CR75", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1182/blood-2003-02-0342", "volume": "103", "author": "HJ. Kolb", "year": "2004", "unstructured": "Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004;103:767\u201376.", "journal-title": "Blood"}, {"key": "20_CR76", "first-page": "3587", "volume": "87", "author": "M. Bocchia", "year": "1996", "unstructured": "Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 1996;87:3587\u201392.", "journal-title": "Blood"}, {"key": "20_CR77", "doi-asserted-by": "crossref", "first-page": "2887", "DOI": "10.1182/blood.V98.10.2887", "volume": "98", "author": "RE. Clark", "year": "2001", "unstructured": "Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, Macintyre AR, Rojas J, Bourdon A, Bonner PL, Wang L, Christmas SE, Travers PJ, Creaser CS, Rees RC, Madrigal JA. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 2001;98:2887\u201393.", "journal-title": "Blood"}, {"key": "20_CR78", "doi-asserted-by": "crossref", "first-page": "2337", "DOI": "10.1084/jem.168.6.2337", "volume": "168", "author": "PJ. Voogt", "year": "1988", "unstructured": "Voogt PJ, Goulmy E, Veenhof WF, Hamilton M, Fibbe WE, Van Rood JJ, Falkenburg JH. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med. 1988;168:2337\u201347.", "journal-title": "J Exp Med."}, {"key": "20_CR79", "first-page": "2336", "volume": "93", "author": "T. Mutis", "year": "1999", "unstructured": "Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999;93:2336\u201341.", "journal-title": "Blood"}, {"key": "20_CR80", "doi-asserted-by": "crossref", "first-page": "2742", "DOI": "10.1073/pnas.0530192100", "volume": "100", "author": "WA Marijt", "year": "2003", "unstructured": "Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA, van Luxemburg-Heys SA, Hoogeboom M, Mutis T, Drijfhout JW, van Rood JJ, Willemze R, Falkenburg JH. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA. 2003;100:2742\u20137.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "20_CR81", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1182/blood-2003-03-0984", "volume": "103", "author": "DB. Miklos", "year": "2004", "unstructured": "Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A, Viatte S, Soiffer RJ, Antin JH, Ritz J. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004;103:353\u20139.", "journal-title": "Blood"}, {"key": "20_CR82", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1182/blood-2003-07-2603", "volume": "103", "author": "SS. Randolph", "year": "2004", "unstructured": "Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004;103:347\u201352.", "journal-title": "Blood"}, {"key": "20_CR83", "first-page": "2450", "volume": "88", "author": "J. Molldrem", "year": "1996", "unstructured": "Molldrem J, Dermime S, Parker K, Jiang YZ, Mavroudis D, Hensel N, Fukushima P, Barrett AJ. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996;88:2450\u20137.", "journal-title": "Blood"}, {"key": "20_CR84", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1038/79526", "volume": "6", "author": "JJ. Molldrem", "year": "2000", "unstructured": "Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE, Davis MM. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med. 2000;6:1018\u201323.", "journal-title": "Nat Med."}, {"key": "20_CR85", "unstructured": "Heslop HE, Stevenson FK, Molldrem JJ. Immunotherapy of hematologic malignancy. Hematology Am Soc Hematol Educ Program. 2003: 331\u201349.", "DOI": "10.1182/asheducation-2003.1.331", "doi-asserted-by": "crossref"}, {"key": "20_CR86", "doi-asserted-by": "crossref", "first-page": "1301", "DOI": "10.1038/sj.leu.2402988", "volume": "17", "author": "C. Rosenfeld", "year": "2003", "unstructured": "Rosenfeld C, Cheever MA, Gaiger A. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 2003;17:1301\u201312.", "journal-title": "Leukemia"}, {"key": "20_CR87", "unstructured": "Atanackovic D, Arfsten J, Cao Y, Gnjatic S, Schnieders F, Bartels K, Schilling G, Faltz C, Wolschke C, Dierlamm J, Ritter G, Eiermann T, Hossfeld DK, Zander AR, Jungbluth AA, Old LJ, Bokemeyer C, Kroger N. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. Blood 1103;109:1103\u201312.", "DOI": "10.1182/blood-2006-04-014480", "doi-asserted-by": "crossref"}, {"key": "20_CR88", "doi-asserted-by": "crossref", "first-page": "4109", "DOI": "10.1182/blood-2006-01-023127", "volume": "108", "author": "J. Greiner", "year": "2006", "unstructured": "Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A, Dohner K, Schlenk RF, Pollack JR, Dohner H, Bullinger L. Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches. Blood 2006;108:4109\u201317.", "journal-title": "Blood"}, {"key": "20_CR89", "first-page": "1781", "volume": "95", "author": "J. Pinilla-Ibarz", "year": "2000", "unstructured": "Pinilla-Ibarz J, Cathcart K, Korontsvit T, Soignet S, Bocchia M, Caggiano J, Lai L, Jimenez J, Kolitz J, Scheinberg DA. Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses. Blood 2000;95:1781\u20137.", "journal-title": "Blood"}, {"key": "20_CR90", "doi-asserted-by": "crossref", "first-page": "2761", "DOI": "10.1182/blood-2007-05-090340", "volume": "110", "author": "JS. Miller", "year": "2007", "unstructured": "Miller JS, Weisdorf DJ, Burns LJ, Slungaard A, Wagner JE, Verneris MR, Cooley S, Wangen R, Fautsch SK, Nicklow R, Defor T, Blazar BR. Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone. Blood 2007;110:2761\u20133.", "journal-title": "Blood"}, {"key": "20_CR91", "doi-asserted-by": "crossref", "first-page": "533", "DOI": "10.1097/00001622-199811000-00010", "volume": "10", "author": "D. Liebowitz", "year": "1998", "unstructured": "Liebowitz D, Lee K, CH J. Costimulatory approaches to adoptive immunotherapy. Curr Opin Oncol. 1998;10:533\u201341.", "journal-title": "Curr Opin Oncol."}, {"key": "20_CR92", "first-page": "5921", "volume": "159", "author": "BL. Levine", "year": "1997", "unstructured": "Levine BL, Bernstein WB, Connors M, Craighead N, Lindsten T, Thompson CB, June CH. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol. 1997;159:5921\u201330.", "journal-title": "J Immunol."}, {"issue": "4", "key": "20_CR93", "doi-asserted-by": "crossref", "first-page": "1325", "DOI": "10.1182/blood-2005-08-3373", "volume": "107", "author": "DL Porter", "year": "2006", "unstructured": "Porter DL, Levin BL, Bunin N, Stadtmauer EA, Luger SM, Goldstein S, Loren A, Phillips J, Nasta S, Perl A, Schuster S, Tsai D, Sohal A, Veloso E, Emerson S, June CH. A Phase I trial of donor lymphocyte infusions expanded and activated ex-vivo via CD3/CD28 co-stimulation. Blood 2006;107(4):1325\u201331.", "journal-title": "Blood"}, {"key": "20_CR94", "doi-asserted-by": "crossref", "first-page": "1150", "DOI": "10.1016/j.bbmt.2006.06.015", "volume": "12", "author": "DH. Fowler", "year": "2006", "unstructured": "Fowler DH, Odom J, Steinberg SM, Chow CK, Foley J, Kogan Y, Hou J, Gea-Banacloche J, Sportes C, Pavletic S, Leitman S, Read EJ, Carter C, Kolstad A, Fox R, Beatty GL, Vonderheide RH, Levine BL, June CH, Gress RE, Bishop MR. Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006;12:1150\u201360.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR95", "first-page": "1471", "volume": "92", "author": "T. Guillaume", "year": "1998", "unstructured": "Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998;92:1471\u201390.", "journal-title": "Blood"}, {"key": "20_CR96", "first-page": "1210", "volume": "11", "author": "LF. Porrata", "year": "2005", "unstructured": "Porrata LF, Gertz MA, Litzow MR, Lacy MQ, Dispenzieri A, Inwards DJ, Ansell SM, Micallef IN, Gastineau DA, Elliott M, Hogan WJ, Hayman SR, Tefferi A, Markovic SN. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res. 2005;11:1210\u20138.", "journal-title": "Clin Cancer Res."}, {"key": "20_CR97", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1080/10245330600667559", "volume": "11", "author": "MR. Boulassel", "year": "2006", "unstructured": "Boulassel MR, Herr AL, de BEMD, Galal A, Lachance S, Laneuville P, Routy JP. Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. Hematology 2006;11:165\u201370.", "journal-title": "Hematology"}, {"key": "20_CR98", "doi-asserted-by": "crossref", "first-page": "2004", "DOI": "10.1182/blood-2003-01-0095", "volume": "102", "author": "GG. Laport", "year": "2003", "unstructured": "Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood 2003;102:2004\u201313.", "journal-title": "Blood"}, {"key": "20_CR99", "doi-asserted-by": "crossref", "first-page": "1230", "DOI": "10.1038/nm1310", "volume": "11", "author": "A. Rapoport", "year": "2005", "unstructured": "Rapoport A, Stadtmauer E, Aqui N, Badros A, Cotte J, Chrisley L, Velosa E, Zheng Z, Westphal S, Mair R, Chi N, Ratterree B, Pochran M, Natt S, Hinkle J, Sickles C, Sohal A, Ruehle K, Lynch C, Zhang L, Porter D, Luger S, Guo C, Fang H, Blackwelder W, Hankey M, Mann D, Edelman R, Frasch C, Levine B, Cross A, June C. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nat Med. 2005;11:1230\u20137.", "journal-title": "Nat Med."}, {"key": "20_CR100", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1146/annurev.immunol.23.021704.115526", "volume": "23", "author": "LL. Lanier", "year": "2005", "unstructured": "Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225\u201374.", "journal-title": "Annu Rev Immunol."}, {"key": "20_CR101", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1126/science.7025208", "volume": "214", "author": "RB. Herberman", "year": "1981", "unstructured": "Herberman RB, Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science 1981;214:24\u201330.", "journal-title": "Science"}, {"key": "20_CR102", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1002/ijc.2910150608", "volume": "15", "author": "R. Kiessling", "year": "1975", "unstructured": "Kiessling R, Petranyi G, Klein G, Wigzel H. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer. 1975;15:933\u201340.", "journal-title": "Int J Cancer."}, {"key": "20_CR103", "doi-asserted-by": "crossref", "first-page": "1499", "DOI": "10.1084/jem.166.5.1499", "volume": "166", "author": "WJ. Murphy", "year": "1987", "unstructured": "Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med. 1987;166:1499\u2013509.", "journal-title": "J Exp Med."}, {"key": "20_CR104", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1084/jem.134.6.1513", "volume": "134", "author": "G. Cudkowicz", "year": "1971", "unstructured": "Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med. 1971;134:1513\u201328.", "journal-title": "J Exp Med."}, {"key": "20_CR105", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1016/S1471-4906(01)02060-9", "volume": "22", "author": "MA. Cooper", "year": "2001", "unstructured": "Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633\u201340.", "journal-title": "Trends Immunol."}, {"key": "20_CR106", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1002/1097-0142(19850315)55:6<1327::AID-CNCR2820550628>3.0.CO;2-O", "volume": "55", "author": "AA. Rayner", "year": "1985", "unstructured": "Rayner AA, Grimm EA, Lotze MT, Chu EW, Rosenberg SA. Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer. Cancer 1985;55:1327\u201333.", "journal-title": "Cancer"}, {"key": "20_CR107", "doi-asserted-by": "crossref", "first-page": "1395", "DOI": "10.1084/jem.180.4.1395", "volume": "180", "author": "WE. Carson", "year": "1994", "unstructured": "Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994;180:1395\u2013403.", "journal-title": "J Exp Med."}, {"key": "20_CR108", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1038/nri1001", "volume": "3", "author": "G. Trinchieri", "year": "2003", "unstructured": "Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133\u201346.", "journal-title": "Nat Rev Immunol."}, {"key": "20_CR109", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1038/sj.cr.7310004", "volume": "16", "author": "HA. Young", "year": "2006", "unstructured": "Young HA, Ortaldo J. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res. 2006;16:20\u201324.", "journal-title": "Cell Res."}, {"key": "20_CR110", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0192-0561(99)00062-4", "volume": "22", "author": "SM. Singh", "year": "2000", "unstructured": "Singh SM, Yanagawa H, Hanibuchi M, Miki T, Okamura H, Sone S. Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. Int J Immunopharmacol. 2000;22:35\u201343.", "journal-title": "Int J Immunopharmacol."}, {"key": "20_CR111", "doi-asserted-by": "crossref", "first-page": "2252", "DOI": "10.1182/blood-2005-03-1154", "volume": "106", "author": "T. Walzer", "year": "2005", "unstructured": "Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: \u201cl\u2019union fait la force\u201d. Blood 2005;106:2252\u20138.", "journal-title": "Blood"}, {"key": "20_CR112", "doi-asserted-by": "crossref", "first-page": "640", "DOI": "10.1002/cncr.22002", "volume": "107", "author": "F. Re", "year": "2006", "unstructured": "Re F, Staudacher C, Zamai L, Vecchio V, Bregni M. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors. Cancer 2006;107:640\u20138.", "journal-title": "Cancer"}, {"key": "20_CR113", "doi-asserted-by": "crossref", "first-page": "6321", "DOI": "10.1158/0008-5472.CAN-04-4252", "volume": "65", "author": "S. Armeanu", "year": "2005", "unstructured": "Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 2005;65:6321\u20139.", "journal-title": "Cancer Res."}, {"key": "20_CR114", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1146/annurev.immunol.20.100201.131730", "volume": "20", "author": "JH. Russell", "year": "2002", "unstructured": "Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20:323\u201370.", "journal-title": "Annu Rev Immunol."}, {"key": "20_CR115", "first-page": "3478", "volume": "141", "author": "LL. Lanier", "year": "1988", "unstructured": "Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988;141:3478\u201385.", "journal-title": "J Immunol."}, {"key": "20_CR116", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1034/j.1399-0039.2003.00072.x", "volume": "62", "author": "SG. Marsh", "year": "2003", "unstructured": "Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 2003;62:79\u201386.", "journal-title": "Tissue Antigens"}, {"key": "20_CR117", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1615/CritRevImmunol.v22.i5-6.70", "volume": "22", "author": "M. Yawata", "year": "2002", "unstructured": "Yawata M, Yawata N, Abi-Rached L, Parham P. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol. 2002;22:463\u201382.", "journal-title": "Crit Rev Immunol."}, {"key": "20_CR118", "doi-asserted-by": "crossref", "first-page": "6640", "DOI": "10.4049/jimmunol.171.12.6640", "volume": "171", "author": "MJ. Pando", "year": "2003", "unstructured": "Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol. 2003;171:6640\u20139.", "journal-title": "J Immunol."}, {"key": "20_CR119", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1006/smim.1995.0013", "volume": "7", "author": "WM. Yokoyama", "year": "1995", "unstructured": "Yokoyama WM, Daniels BF, Seaman WE, Hunziker R, Margulies DH, Smith HR. A family of murine NK cell receptors specific for target cell MHC class I molecules. Semin Immunol. 1995;7:89\u2013101.", "journal-title": "Semin Immunol."}, {"key": "20_CR120", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1016/S1074-7613(00)80616-0", "volume": "9", "author": "M. Vales-Gomez", "year": "1998", "unstructured": "Vales-Gomez M, Reyburn HT, Mandelboim M, Strominger JL. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 1998;9:337\u201344.", "journal-title": "Immunity"}, {"key": "20_CR121", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1084/jem.173.4.1017", "volume": "173", "author": "JP. Houchins", "year": "1991", "unstructured": "Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med. 1991;173:1017\u201320.", "journal-title": "J Exp Med."}, {"key": "20_CR122", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1111/j.1399-0039.2004.00210.x", "volume": "63", "author": "M. Lopez-Botet", "year": "2004", "unstructured": "Lopez-Botet M, Angulo A, Guma M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens. 2004;63:195\u2013203.", "journal-title": "Tissue Antigens."}, {"key": "20_CR123", "doi-asserted-by": "crossref", "first-page": "18922", "DOI": "10.1074/jbc.M702504200", "volume": "282", "author": "W. Cao", "year": "2007", "unstructured": "Cao W, Xi X, Hao Z, Li W, Kong Y, Cui L, Ma C, Ba D, He W. RAET1E2, a soluble isoform of the UL16 binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. J Biol Chem. 2007;282:18922\u20138.", "journal-title": "J Biol Chem."}, {"key": "20_CR124", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/0167-5699(90)90097-S", "volume": "11", "author": "HG. Ljunggren", "year": "1990", "unstructured": "Ljunggren HG, Karre K. In search of the \u201dmissing self\u201d: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237\u201344.", "journal-title": "Immunol Today."}, {"key": "20_CR125", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1016/S1074-7613(00)80393-3", "volume": "7", "author": "NM. Valiante", "year": "1997", "unstructured": "Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D\u2019Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739\u201351.", "journal-title": "Immunity"}, {"key": "20_CR126", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1146/annurev.immunol.19.1.291", "volume": "19", "author": "DH. Raulet", "year": "2001", "unstructured": "Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001;19:291\u2013330.", "journal-title": "Annu Rev Immunol."}, {"key": "20_CR127", "doi-asserted-by": "crossref", "first-page": "4416", "DOI": "10.1182/blood-2004-08-3156", "volume": "105", "author": "NC. Fernandez", "year": "2005", "unstructured": "Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005;105:4416\u201323.", "journal-title": "Blood"}, {"key": "20_CR128", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/j.immuni.2006.06.013", "volume": "25", "author": "N. Anfossi", "year": "2006", "unstructured": "Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006;25:331\u201342.", "journal-title": "Immunity"}, {"key": "20_CR129", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1182/blood-2006-07-036228", "volume": "110", "author": "S. Cooley", "year": "2007", "unstructured": "Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann T, McQueen KL, Guethlein LA, Parham P, Miller JS. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self MHC is developmentally immature. Blood 2007;110:578\u201386.", "journal-title": "Blood"}, {"key": "20_CR130", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1038/386510a0", "volume": "386", "author": "HE. Farrell", "year": "1997", "unstructured": "Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997;386:510\u20134.", "journal-title": "Nature"}, {"key": "20_CR131", "doi-asserted-by": "crossref", "first-page": "13483", "DOI": "10.1073/pnas.2233572100", "volume": "100", "author": "V Voigt", "year": "2003", "unstructured": "Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, Yokoyama WM, Scalzo AA. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA. 2003;100:13483\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "20_CR132", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1038/ng2035", "volume": "39", "author": "MP. Martin", "year": "2007", "unstructured": "Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O\u2019Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39:733\u201340.", "journal-title": "Nat Genet."}, {"key": "20_CR133", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1038/nri2038", "volume": "7", "author": "G. Trinchieri", "year": "2007", "unstructured": "Trinchieri G, Sher A. Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7:179\u201390.", "journal-title": "Nat Rev Immunol."}, {"key": "20_CR134", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1182/blood.V98.3.705", "volume": "98", "author": "JS. Miller", "year": "2001", "unstructured": "Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 2001;98:705\u201313.", "journal-title": "Blood"}, {"key": "20_CR135", "first-page": "3647", "volume": "92", "author": "H. Yu", "year": "1998", "unstructured": "Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, Carson WE, Caligiuri MA. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 1998;92:3647\u201357.", "journal-title": "Blood"}, {"key": "20_CR136", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1016/S0301-472X(00)00490-2", "volume": "28", "author": "MO. Muench", "year": "2000", "unstructured": "Muench MO, Humeau L, Paek B, Ohkubo T, Lanier LL, Albanese CT, Barcena A. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors. Exp Hematol. 2000;28:961\u201373.", "journal-title": "Exp Hematol."}, {"key": "20_CR137", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1084/jem.20052507", "volume": "203", "author": "AG. Freud", "year": "2006", "unstructured": "Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, Caligiuri MA. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med. 2006;203:1033\u201343.", "journal-title": "J Exp Med."}, {"key": "20_CR138", "doi-asserted-by": "crossref", "first-page": "2591", "DOI": "10.4049/jimmunol.174.5.2591", "volume": "174", "author": "PA. Antony", "year": "2005", "unstructured": "Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol. 2005;174:2591\u2013601.", "journal-title": "J Immunol."}, {"key": "20_CR139", "doi-asserted-by": "crossref", "first-page": "4135", "DOI": "10.4049/jimmunol.174.7.4135", "volume": "174", "author": "HI. Trompeter", "year": "2005", "unstructured": "Trompeter HI, Gomez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C, Uhrberg M. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol. 2005;174:4135\u201343.", "journal-title": "J Immunol."}, {"key": "20_CR140", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1016/S1074-7613(00)80394-5", "volume": "7", "author": "M. Uhrberg", "year": "1997", "unstructured": "Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753\u201363.", "journal-title": "Immunity"}, {"key": "20_CR141", "doi-asserted-by": "crossref", "first-page": "3415", "DOI": "10.4049/jimmunol.171.7.3415", "volume": "171", "author": "A. Kikuchi-Maki", "year": "2003", "unstructured": "Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol. 2003;171:3415\u201325.", "journal-title": "J Immunol."}, {"key": "20_CR142", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1034/j.1399-0039.2002.600307.x", "volume": "60", "author": "LD. Maxwell", "year": "2002", "unstructured": "Maxwell LD, Wallace A, Middleton D, Curran MD. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002;60:254\u20138.", "journal-title": "Tissue Antigens"}, {"key": "20_CR143", "doi-asserted-by": "crossref", "first-page": "6540", "DOI": "10.4049/jimmunol.174.10.6540", "volume": "174", "author": "W. Leung", "year": "2005", "unstructured": "Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS, Houston J, Handgretinger R. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol. 2005;174:6540\u20135.", "journal-title": "J Immunol."}, {"key": "20_CR144", "doi-asserted-by": "crossref", "first-page": "4370", "DOI": "10.1182/blood-2005-04-1644", "volume": "106", "author": "S. Cooley", "year": "2005", "unstructured": "Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, Miller JS. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005;106:4370\u20136.", "journal-title": "Blood"}, {"key": "20_CR145", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1111/j.1600-065X.2006.00460.x", "volume": "214", "author": "S. Gasser", "year": "2006", "unstructured": "Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev. 2006;214:130\u201342.", "journal-title": "Immunol Rev."}, {"key": "20_CR146", "doi-asserted-by": "crossref", "first-page": "1810", "DOI": "10.1182/blood-2004-05-1947", "volume": "105", "author": "EP. Alyea", "year": "2005", "unstructured": "Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ, Lee SJ, Windawi S, Ritz J, Stone RM, Antin JH, Soiffer RJ. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005;105:1810\u20134.", "journal-title": "Blood"}, {"key": "20_CR147", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1111/j.1600-065X.2006.00458.x", "volume": "214", "author": "WM. Yokoyama", "year": "2006", "unstructured": "Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev. 2006;214:143\u201354.", "journal-title": "Immunol Rev."}, {"key": "20_CR148", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1111/j.1600-065X.2006.00462.x", "volume": "214", "author": "P. Parham", "year": "2006", "unstructured": "Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev. 2006;214:155\u201360.", "journal-title": "Immunol Rev."}, {"key": "20_CR149", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1056/NEJM198704093161501", "volume": "316", "author": "SA. Rosenberg", "year": "1987", "unstructured": "Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987;316:889\u201397.", "journal-title": "N Engl J Med."}, {"key": "20_CR150", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1038/sj.bmt.1704086", "volume": "32", "author": "LJ. Burns", "year": "2003", "unstructured": "Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone Marrow Transplant. 2003;32:177\u201386.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR151", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1172/JCI0215175", "volume": "110", "author": "W. Dummer", "year": "2002", "unstructured": "Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest. 2002;110:185\u201392.", "journal-title": "J Clin Invest."}, {"key": "20_CR152", "doi-asserted-by": "crossref", "first-page": "850", "DOI": "10.1126/science.1076514", "volume": "298", "author": "ME. Dudley", "year": "2002", "unstructured": "Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002;298:850\u20134.", "journal-title": "Science"}, {"key": "20_CR153", "doi-asserted-by": "crossref", "first-page": "2097", "DOI": "10.1126/science.1068440", "volume": "295", "author": "L. Ruggeri", "year": "2002", "unstructured": "Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097\u2013100.", "journal-title": "Science"}, {"key": "20_CR154", "doi-asserted-by": "crossref", "first-page": "668", "DOI": "10.1038/ncponc0666", "volume": "3", "author": "P. Muranski", "year": "2006", "unstructured": "Muranski P, Boni A, Wrzesinski C, Citrin DE, Rosenberg SA, Childs R, Restifo NP. Increased intensity lymphodepletion and adoptive immunotherapy \u2013 how far can we go? Nat Clin Pract Oncol. 2006;3:668\u201381.", "journal-title": "Nat Clin Pract Oncol."}, {"key": "20_CR155", "doi-asserted-by": "crossref", "first-page": "3051", "DOI": "10.1182/blood-2004-07-2974", "volume": "105", "author": "JS. Miller", "year": "2005", "unstructured": "Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, Orchard PJ, Blazar BR, Wagner JE, Slungaard A, Weisdorf DJ, Okazaki IJ, McGlave PB. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005;105:3051\u20137.", "journal-title": "Blood"}, {"key": "20_CR156", "doi-asserted-by": "crossref", "first-page": "1533", "DOI": "10.1016/S0301-472X(99)00089-2", "volume": "27", "author": "S. Cooley", "year": "1999", "unstructured": "Cooley S, Burns LJ, Repka T, Miller JS. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol. 1999;27:1533\u201341.", "journal-title": "Exp Hematol."}, {"key": "20_CR157", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1182/blood-2003-12-4438", "volume": "104", "author": "T. Igarashi", "year": "2004", "unstructured": "Igarashi T, Wynberg J, Srinivasan R, Becknell B, McCoy JP Jr, Takahashi Y, Suffredini DA, Linehan WM, Caligiuri MA, Childs RW. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 2004;104:170\u20137.", "journal-title": "Blood"}, {"key": "20_CR158", "doi-asserted-by": "crossref", "first-page": "1712", "DOI": "10.1097/01.tp.0000250935.41034.2d", "volume": "82", "author": "M. Ohira", "year": "2006", "unstructured": "Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, Asahara T. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation 2006;82:1712\u20139.", "journal-title": "Transplantation"}, {"key": "20_CR159", "doi-asserted-by": "crossref", "first-page": "1835", "DOI": "10.1038/sj.leu.2403524", "volume": "18", "author": "JR. Passweg", "year": "2004", "unstructured": "Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kuhne T, Favre G, Gratwohl A. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia 2004;18:1835\u20138.", "journal-title": "Leukemia"}, {"key": "20_CR160", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1055/s-2005-872520", "volume": "217", "author": "U. Koehl", "year": "2005", "unstructured": "Koehl U, Esser R, Zimmermann S, Tonn T, Kotchetkov R, Bartling T, Sorensen J, Gruttner HP, Bader P, Seifried E, Martin H, Lang P, Passweg JR, Klingebiel T, Schwabe D. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Klin Padiatr. 2005;217:345\u201350.", "journal-title": "Klin Padiatr."}, {"key": "20_CR161", "doi-asserted-by": "crossref", "first-page": "3132", "DOI": "10.1182/blood.V97.10.3132", "volume": "97", "author": "CY. Koh", "year": "2001", "unstructured": "Koh CY, Blazar BR, George T, Welniak LA, Capitini CM, Raziuddin A, Murphy WJ, Bennett M. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 2001;97:3132\u20137.", "journal-title": "Blood"}, {"key": "20_CR162", "doi-asserted-by": "crossref", "first-page": "5460", "DOI": "10.1073/pnas.0509249103", "volume": "103", "author": "I Barao", "year": "2006", "unstructured": "Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA. 2006;103:5460\u20135.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "20_CR163", "doi-asserted-by": "crossref", "first-page": "1160", "DOI": "10.1016/j.exphem.2005.06.024", "volume": "33", "author": "G. Suck", "year": "2005", "unstructured": "Suck G, Branch DR, Smyth MJ, Miller RG, Vergidis J, Fahim S, Keating A. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. Exp Hematol. 2005;33:1160\u201371.", "journal-title": "Exp Hematol."}, {"key": "20_CR164", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1016/j.semcancer.2006.07.006", "volume": "16", "author": "G. Suck", "year": "2006", "unstructured": "Suck G. Novel approaches using natural killer cells in cancer therapy. Semin Cancer Biol. 2006;16:412\u20138.", "journal-title": "Semin Cancer Biol."}, {"key": "20_CR165", "first-page": "1265", "volume": "100", "author": "C. Uherek", "year": "2002", "unstructured": "Uherek C, Tonn T, Uherek B, Becker S, Schnierle B, Klingemann HG, Wels W. Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood 2002;100:1265\u201373.", "journal-title": "Blood"}, {"key": "20_CR166", "doi-asserted-by": "crossref", "first-page": "2180", "DOI": "10.1182/blood-2003-04-1164", "volume": "102", "author": "S. Jiang", "year": "2003", "unstructured": "Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4+ CD25+ regulatory T cells ex vivo. Blood 2003;102:2180\u20136.", "journal-title": "Blood"}, {"key": "20_CR167", "doi-asserted-by": "crossref", "first-page": "1693", "DOI": "10.1084/jem.20060468", "volume": "203", "author": "N. Seddiki", "year": "2006", "unstructured": "Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203:1693\u20131700.", "journal-title": "J Exp Med."}, {"key": "20_CR168", "doi-asserted-by": "crossref", "first-page": "1144", "DOI": "10.1038/nm915", "volume": "9", "author": "M. Edinger", "year": "2003", "unstructured": "Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS. CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. [see comment]. Nat Med. 2003;9:1144\u201350.", "journal-title": "Nat Med."}, {"key": "20_CR169", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1016/j.bbmt.2006.01.005", "volume": "12", "author": "P. Hoffmann", "year": "2006", "unstructured": "Hoffmann P, Boeld TJ, Eder R, Albrecht J, Doser K, Piseshka B, Dada A, Niemand C, Assenmacher M, Orso E, Andreesen R, Holler E, Edinger M. Isolation of CD4+ CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant. 2006;12:267\u201374.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR170", "doi-asserted-by": "crossref", "first-page": "4743", "DOI": "10.1182/blood-2004-10-3932", "volume": "105", "author": "M. Battaglia", "year": "2005", "unstructured": "Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 2005;105:4743\u20138.", "journal-title": "Blood"}, {"key": "20_CR171", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1080/14653240601145223", "volume": "9", "author": "CA. Keever-Taylor", "year": "2007", "unstructured": "Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy 2007;9:144\u201357.", "journal-title": "Cytotherapy"}, {"key": "20_CR172", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1038/nri2138", "volume": "7", "author": "MG. Roncarolo", "year": "2007", "unstructured": "Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7:585\u201398.", "journal-title": "Nat Rev Immunol."}, {"key": "20_CR173", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1038/39614", "volume": "389", "author": "H. Groux", "year": "1997", "unstructured": "Groux H, O\u2019Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737\u201342.", "journal-title": "Nature"}, {"key": "20_CR174", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1126/science.284.5411.143", "volume": "284", "author": "MF. Pittenger", "year": "1999", "unstructured": "Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143\u20137.", "journal-title": "Science"}, {"key": "20_CR175", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1080/14653240500319234", "volume": "7", "author": "EM. Horwitz", "year": "2005", "unstructured": "Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393\u20135.", "journal-title": "Cytotherapy"}, {"key": "20_CR176", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7", "volume": "176", "author": "MK. Majumdar", "year": "1998", "unstructured": "Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998;176:57\u201366.", "journal-title": "J Cell Physiol."}, {"key": "20_CR177", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1046/j.1365-3083.2003.01176.x", "volume": "57", "author": "K. Blanc Le", "year": "2003", "unstructured": "Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11\u201320.", "journal-title": "Scand J Immunol."}, {"key": "20_CR178", "doi-asserted-by": "crossref", "first-page": "1815", "DOI": "10.1182/blood-2004-04-1559", "volume": "105", "author": "S. Aggarwal", "year": "2005", "unstructured": "Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815\u201322.", "journal-title": "Blood"}, {"key": "20_CR179", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1038/sj.bmt.1704400", "volume": "33", "author": "B. Maitra", "year": "2004", "unstructured": "Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Koc ON. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004;33:597\u2013604.", "journal-title": "Bone Marrow Transplant."}, {"key": "20_CR180", "doi-asserted-by": "crossref", "first-page": "870", "DOI": "10.1016/S0301-472X(02)00820-2", "volume": "30", "author": "WA. Noort", "year": "2002", "unstructured": "Noort WA, Kruisselbrink AB, in\u2019t Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MH, Lowik CW, Falkenburg JH, Willemze R, Fibbe WE. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002;30:870\u20138.", "journal-title": "Exp Hematol."}, {"key": "20_CR181", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1200/JCO.2000.18.2.307", "volume": "18", "author": "ON. Koc", "year": "2000", "unstructured": "Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307\u201316.", "journal-title": "J Clin Oncol."}, {"key": "20_CR182", "doi-asserted-by": "crossref", "first-page": "1439", "DOI": "10.1016/S0140-6736(04)16104-7", "volume": "363", "author": "K. Blanc Le", "year": "2004", "unstructured": "Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439\u201341.", "journal-title": "Lancet"}, {"key": "20_CR183", "doi-asserted-by": "crossref", "first-page": "1390", "DOI": "10.1097/01.tp.0000214462.63943.14", "volume": "81", "author": "O. Ringden", "year": "2006", "unstructured": "Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390\u20137.", "journal-title": "Transplantation"}, {"key": "20_CR184", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1016/j.bbmt.2005.02.001", "volume": "11", "author": "HM. Lazarus", "year": "2005", "unstructured": "Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005;11:389\u201398.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "20_CR185", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1182/blood-2002-02-0350", "volume": "100", "author": "SS. Farag", "year": "2002", "unstructured": "Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002;100:1935\u201347.", "journal-title": "Blood"}], "container-title": ["Cancer Treatment and Research", "Hematopoietic Stem Cell Transplantation"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-0-387-78580-6_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 26]], "date-time": "2019-04-26T08:53:42Z", "timestamp": 1556268822000}, "score": 37.514404, "issued": {"date-parts": [[2008, 10, 31]]}, "ISBN": ["9780387785790", "9780387785806"], "references-count": 185, "URL": "http://dx.doi.org/10.1007/978-0-387-78580-6_20", "relation": {"cites": []}, "ISSN": ["0927-3042"], "issn-type": [{"value": "0927-3042", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:41:39Z", "timestamp": 1575322899163}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Microbiology"], "published-print": {"date-parts": [[2009, 1, 1]]}, "DOI": "10.1128/jcm.01670-08", "type": "journal-article", "created": {"date-parts": [[2008, 11, 13]], "date-time": "2008-11-13T01:58:25Z", "timestamp": 1226541505000}, "page": "278-281", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Disseminated Fusariosis Caused by Fusarium verticillioides in an Acute Lymphoblastic Leukemia Patient after Allogeneic Hematopoietic Stem Cell Transplantation"], "prefix": "10.1128", "volume": "47", "author": [{"given": "G.", "family": "Tezcan", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Ozhak-Baysan", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Alastruey-Izquierdo", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Ogunc", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Ongut", "sequence": "additional", "affiliation": []}, {"given": "S. T.", "family": "Yildiran", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Hazar", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Cuenca-Estrella", "sequence": "additional", "affiliation": []}, {"given": "J. L.", "family": "Rodriguez-Tudela", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2008, 11, 12]]}, "container-title": ["Journal of Clinical Microbiology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JCM.01670-08", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T15:46:36Z", "timestamp": 1482507996000}, "score": 37.130745, "issued": {"date-parts": [[2008, 11, 12]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 1, 2]]}, "published-print": {"date-parts": [[2009, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1128/jcm.01670-08", "ISSN": ["0095-1137"], "issn-type": [{"value": "0095-1137", "type": "print"}], "subject": ["Microbiology (medical)"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:52:21Z", "timestamp": 1574131941288}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 6, 1]], "date-time": "2002-06-01T00:00:00Z", "timestamp": 1022889600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Hematol"], "published-print": {"date-parts": [[2002, 6]]}, "DOI": "10.1007/s00277-002-0469-0", "type": "journal-article", "created": {"date-parts": [[2003, 2, 12]], "date-time": "2003-02-12T19:12:20Z", "timestamp": 1045077140000}, "page": "343-346", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation"], "prefix": "10.1007", "volume": "81", "author": [{"given": "M.", "family": "Henkes", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Martin", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Einsele", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Aulitzky", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2002, 6, 4]]}, "container-title": ["Annals of Hematology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00277-002-0469-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00277-002-0469-0/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00277-002-0469-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T18:03:54Z", "timestamp": 1558721034000}, "score": 36.54147, "issued": {"date-parts": [[2002, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002, 6]]}, "issue": "6"}, "alternative-id": ["469"], "URL": "http://dx.doi.org/10.1007/s00277-002-0469-0", "ISSN": ["0939-5555", "1432-0584"], "issn-type": [{"value": "0939-5555", "type": "print"}, {"value": "1432-0584", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:13:57Z", "timestamp": 1574529237305}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 2, 1]], "date-time": "2013-02-01T00:00:00Z", "timestamp": 1359676800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2015, 4, 10]], "date-time": "2015-04-10T00:00:00Z", "timestamp": 1428624000000}, "delay-in-days": 798, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biology of Blood and Marrow Transplantation"], "published-print": {"date-parts": [[2013, 2]]}, "DOI": "10.1016/j.bbmt.2012.11.355", "type": "journal-article", "created": {"date-parts": [[2013, 1, 23]], "date-time": "2013-01-23T18:17:35Z", "timestamp": 1358965055000}, "page": "S262", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Low Dose Liposomal Amphotericin B Followed by Micafungin Prophylaxis of Invasive Fungal Infections (IFI) in Pediatric Allogeneic Stem Cell Transplantation Recipients"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Mona", "family": "Elmacken", "sequence": "first", "affiliation": []}, {"given": "Christopher", "family": "Ours", "sequence": "additional", "affiliation": []}, {"given": "Daniel", "family": "Mitchell", "sequence": "additional", "affiliation": []}, {"given": "Olga", "family": "Militano", "sequence": "additional", "affiliation": []}, {"given": "Carmella", "family": "van de Ven", "sequence": "additional", "affiliation": []}, {"given": "Mitchell S.", "family": "Cairo", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biology of Blood and Marrow Transplantation"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1083879112008646?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1083879112008646?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 7, 15]], "date-time": "2018-07-15T06:07:15Z", "timestamp": 1531634835000}, "score": 35.877773, "issued": {"date-parts": [[2013, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 2]]}, "issue": "2"}, "alternative-id": ["S1083879112008646"], "URL": "http://dx.doi.org/10.1016/j.bbmt.2012.11.355", "ISSN": ["1083-8791"], "issn-type": [{"value": "1083-8791", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T05:40:57Z", "timestamp": 1574142057642}, "reference-count": 6, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 11, 1]], "date-time": "2002-11-01T00:00:00Z", "timestamp": 1036108800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transplantation Proceedings"], "published-print": {"date-parts": [[2002, 11]]}, "DOI": "10.1016/s0041-1345(02)03493-0", "type": "journal-article", "created": {"date-parts": [[2002, 11, 12]], "date-time": "2002-11-12T17:32:32Z", "timestamp": 1037122352000}, "page": "2931-2933", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation"], "prefix": "10.1016", "volume": "34", "author": [{"given": "I.P", "family": "Zupan", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Zver", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Pretnar", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Transplantation Proceedings"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0041134502034930?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0041134502034930?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T16:55:16Z", "timestamp": 1554224116000}, "score": 35.75193, "issued": {"date-parts": [[2002, 11]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[2002, 11]]}, "issue": "7"}, "alternative-id": ["S0041134502034930"], "URL": "http://dx.doi.org/10.1016/s0041-1345(02)03493-0", "ISSN": ["0041-1345"], "issn-type": [{"value": "0041-1345", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:16:00Z", "timestamp": 1574453760864}, "reference-count": 8, "publisher": "Springer Science and Business Media LLC", "issue": "10", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 2, 20]], "date-time": "2012-02-20T00:00:00Z", "timestamp": 1329696000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bone Marrow Transplant"], "published-print": {"date-parts": [[2012, 10]]}, "DOI": "10.1038/bmt.2012.16", "type": "journal-article", "created": {"date-parts": [[2012, 2, 20]], "date-time": "2012-02-20T12:38:36Z", "timestamp": 1329741516000}, "page": "1368-1369", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor"], "prefix": "10.1038", "volume": "47", "author": [{"given": "J", "family": "Ammer", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Prantl", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Holler", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Landfried", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Wolff", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Karrer", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Andreesen", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Holler", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 2, 20]]}, "reference": [{"key": "BFbmt201216_CR1", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1097/00007890-198508000-00027", "volume": "40", "author": "HY Knobler", "year": "1985", "unstructured": "Knobler HY, Sagher U, Peled IJ, Wexler MR, Steiner D, Rubinstein N et al. Tolerance to donor-type skin in the recipient of a bone marrow allograft: Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 1985; 40: 223\u2013225.", "journal-title": "Transplantation"}, {"key": "BFbmt201216_CR2", "first-page": "152", "volume": "60", "author": "S Kondo", "year": "1994", "unstructured": "Kondo S, Tamura K, Makino S, Takamatsu Y . Allogeneic skin grafting for extensive skin chronic graft-versus-host disease. Int J Hematol 1994; 60: 152\u2013155.", "journal-title": "Int J Hematol"}, {"key": "BFbmt201216_CR3", "first-page": "438", "volume": "61", "author": "RG Baumeister", "year": "1990", "unstructured": "Baumeister RG, Riel KA, Kolb HJ . Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation]. Chirurg 1990; 61: 438\u2013440.", "journal-title": "Chirurg"}, {"key": "BFbmt201216_CR4", "first-page": "1530", "volume": "56", "author": "Y Kamei", "year": "1993", "unstructured": "Kamei Y, Torii S, Hasegawa M, Toriyama, K, Kodera Y . Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient. Transplantation 1993; 56: 1530\u20131531.", "journal-title": "Transplantation"}, {"key": "BFbmt201216_CR5", "first-page": "1153", "volume": "46", "author": "R Crocchialo", "year": "2010", "unstructured": "Crocchialo R, Nicolini FE, Sobh M, Ducastelle-Lepretre S, Lubussiere H, Dubois V et al. Treatment of a severe extensive cutaneous chronic GVHD after allo-HSCT using glycerolyzed skin allografts and cultured epidermis from the same donor. BMT 2010; 46: 1153.", "journal-title": "BMT"}, {"key": "BFbmt201216_CR6", "doi-asserted-by": "publisher", "first-page": "1512", "DOI": "10.1016/j.bjps.2007.11.015", "volume": "61", "author": "JO Berg", "year": "2008", "unstructured": "Berg JO, Vindelov L, Schmidt G, Drzewiecki KT . Allogeneic split-skin grafting in stem cell transplanted patients. J Plast Reconstr Aesthet Surg 2008; 61: 1512\u20131515.", "journal-title": "J Plast Reconstr Aesthet Surg"}, {"key": "BFbmt201216_CR7", "doi-asserted-by": "publisher", "first-page": "314", "DOI": "10.1111/j.0105-2896.2006.00422.x", "volume": "212", "author": "S Yamayaki", "year": "2006", "unstructured": "Yamayaki S, Inaba K, Tarbell KV, Steinman RM . Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 2006; 212: 314\u2013329.", "journal-title": "Immunol Rev"}, {"key": "BFbmt201216_CR8", "doi-asserted-by": "publisher", "first-page": "1066", "DOI": "10.1016/j.micinf.2005.03.035", "volume": "7", "author": "P Hoffmann", "year": "2005", "unstructured": "Hoffmann P, Boeld TJ, Pisekshka B, Edinger M . Immunomodulation after allogeneic bone marrow transplantation by CD4+CD25+ regulatory T cells. Microbes Infect 2005; 7: 1066\u20131072.", "journal-title": "Microbes Infect"}], "container-title": ["Bone Marrow Transplantation"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bmt201216.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bmt201216", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bmt201216.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T02:17:24Z", "timestamp": 1555208244000}, "score": 35.4343, "issued": {"date-parts": [[2012, 2, 20]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2012, 10]]}, "issue": "10"}, "alternative-id": ["BFbmt201216"], "URL": "http://dx.doi.org/10.1038/bmt.2012.16", "relation": {"cites": []}, "ISSN": ["0268-3369", "1476-5365"], "issn-type": [{"value": "0268-3369", "type": "print"}, {"value": "1476-5365", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T14:45:15Z", "timestamp": 1575211515113}, "publisher-location": "Totowa, NJ", "reference-count": 204, "publisher": "Humana Press", "isbn-type": [{"value": "9781475744811", "type": "print"}, {"value": "9781592593330", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003]]}, "DOI": "10.1007/978-1-59259-333-0_25", "type": "book-chapter", "created": {"date-parts": [[2013, 4, 17]], "date-time": "2013-04-17T05:42:24Z", "timestamp": 1366177344000}, "page": "387-410", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Allogeneic Effector Cell Populations"], "prefix": "10.1007", "author": [{"given": "Michael R.", "family": "Verneris", "sequence": "first", "affiliation": []}, {"given": "Robert S.", "family": "Negrin", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "25_CR1", "first-page": "401", "volume": "244", "author": "A Fefer", "year": "1987", "unstructured": "Fefer A, Sullivan KM, Weiden P, et al. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Prog Clin Biol Res 1987; 244: 401\u2013408.", "journal-title": "Prog Clin Biol Res"}, {"key": "25_CR2", "first-page": "1269", "volume": "76", "author": "A Fefer", "year": "1986", "unstructured": "Fefer A, Cheever MA, Greenberg PD. Identical-twin (syngeneic) marrow transplantation for hematologic cancers. J Natl Cancer Inst 1986; 76: 1269\u20131273.", "journal-title": "J Natl Cancer Inst"}, {"key": "25_CR3", "doi-asserted-by": "publisher", "first-page": "1068", "DOI": "10.1056/NEJM197905103001902", "volume": "300", "author": "PL Weiden", "year": "1979", "unstructured": "Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068\u20131073.", "journal-title": "N Engl J Med"}, {"key": "25_CR4", "doi-asserted-by": "publisher", "first-page": "646", "DOI": "10.7326/0003-4819-120-8-199404150-00004", "volume": "120", "author": "RP Gale", "year": "1994", "unstructured": "Gale RP, Horowitz MM, Ash RC, et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646\u2013652.", "journal-title": "Ann Intern Med"}, {"key": "25_CR5", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1056/NEJM197707212970307", "volume": "297", "author": "A Fefer", "year": "1977", "unstructured": "Fefer A, Buckner CD, Thomas ED, et al. Cure of hematologic neoplasia with transplantation of marrow from identical twins. N Engl J Med 1977; 297: 146\u2013148.", "journal-title": "N Engl J Med"}, {"key": "25_CR6", "first-page": "555", "volume": "75", "author": "MM Horowitz", "year": "1990", "unstructured": "Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.", "journal-title": "Blood"}, {"key": "25_CR7", "first-page": "509", "volume": "58", "author": "FR Appelbaum", "year": "1981", "unstructured": "Appelbaum FR, Fefer A, Cheever MA, et al. Treatment of non-Hodgkin\u2019 s lymphoma with marrow transplantation in identical twins. Blood 1981; 58: 509\u2013513.", "journal-title": "Blood"}, {"key": "25_CR8", "doi-asserted-by": "publisher", "first-page": "1755", "DOI": "10.1016/S0140-6736(98)11135-2", "volume": "353", "author": "M Sykes", "year": "1999", "unstructured": "Sykes M, Preffer F, McAfee S, et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet 1999; 353: 1755\u20131759.", "journal-title": "Lancet"}, {"key": "25_CR9", "doi-asserted-by": "publisher", "first-page": "396", "DOI": "10.1046/j.1365-2141.1999.01706.x", "volume": "107", "author": "R Childs", "year": "1999", "unstructured": "Childs R, Epperson D, Bahceci E, Clave E, Barrett J. Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect. Br J Haematol 1999; 107: 396\u2013400.", "journal-title": "Br J Haematol"}, {"key": "25_CR10", "first-page": "756", "volume": "91", "author": "S Slavin", "year": "1998", "unstructured": "Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.", "journal-title": "Blood"}, {"issue": "1", "key": "25_CR11", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1034/j.1399-3046.1999.00054.x", "volume": "3", "author": "R Champlin", "year": "1999", "unstructured": "Champlin R, Khouri I, Giralt S. Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality. Pediatr Transplant 1999; 3 (Suppl 1): 52\u201358.", "journal-title": "Pediatr Transplant"}, {"key": "25_CR12", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1007/978-1-4615-4987-1_5", "volume": "101", "author": "S Giralt", "year": "1999", "unstructured": "Giralt S, Khouri I, Champlin R. Non myeloablative \u201cmini transplants.\u201d Cancer Treat Res 1999; 101: 97\u2013108.", "journal-title": "Cancer Treat Res"}, {"issue": "2", "key": "25_CR13", "doi-asserted-by": "publisher", "first-page": "S54", "DOI": "10.1038/sj.bmt.1702356", "volume": "25", "author": "S Slavin", "year": "2000", "unstructured": "Slavin S, Or R, Prighozina T, et al. Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man. Bone Marrow Transplant 2000; 25 (Suppl2): S54\u201357.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR14", "doi-asserted-by": "publisher", "first-page": "18", "DOI": "10.1046/j.1365-2141.2000.02196.x", "volume": "111", "author": "R Champlin", "year": "2000", "unstructured": "Champlin R, Khouri I, Shimoni A, et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000; 111: 18\u201329.", "journal-title": "Br J Haematol"}, {"key": "25_CR15", "first-page": "1720", "volume": "73", "author": "KM Sullivan", "year": "1989", "unstructured": "Sullivan KM, Weiden PL, Storb R, et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720\u20131728.", "journal-title": "Blood"}, {"key": "25_CR16", "first-page": "921", "volume": "18", "author": "O Ringden", "year": "1996", "unstructured": "Ringden O, Labopin M, Gluckman E, et al. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996; 18: 921\u2013929.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR17", "first-page": "2462", "volume": "76", "author": "HJ Kolb", "year": "1990", "unstructured": "Kolb HJ, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462\u20132465.", "journal-title": "Blood"}, {"key": "25_CR18", "doi-asserted-by": "publisher", "first-page": "1130", "DOI": "10.1046/j.1365-2141.2000.02493.x", "volume": "111", "author": "O Ringden", "year": "2000", "unstructured": "Ringden O, Labopin M, Gorin NC, et al. Is there a graft-versus-leukaemia effect in the absence of graft-versushost disease in patients undergoing bone marrow transplantation for acute leukaemia? Br J Haematol 2000; 111: 1130\u20131137.", "journal-title": "Br J Haematol"}, {"key": "25_CR19", "first-page": "3671", "volume": "91", "author": "EP Alyea", "year": "1998", "unstructured": "Alyea EP, Soiffer RJ, Canning C, et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998; 91: 3671\u20133680.", "journal-title": "Blood"}, {"key": "25_CR20", "first-page": "1261", "volume": "86", "author": "S Mackinnon", "year": "1995", "unstructured": "Mackinnon S, Papadopoulos EB, Carabasi MH, et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261\u20131268.", "journal-title": "Blood"}, {"key": "25_CR21", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1111/j.1600-065X.1990.tb00562.x", "volume": "114", "author": "M Patarroyo", "year": "1990", "unstructured": "Patarroyo M, Prieto J, Rincon J, et al. Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol Rev 1990; 114: 67\u2013108.", "journal-title": "Immunol Rev"}, {"key": "25_CR22", "doi-asserted-by": "publisher", "first-page": "849", "DOI": "10.1016/0092-8674(86)90007-3", "volume": "44", "author": "JD Young", "year": "1986", "unstructured": "Young JD, Hengartner H, Podack ER, Cohn ZA. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 1986; 44: 849\u2013859.", "journal-title": "Cell"}, {"key": "25_CR23", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1084/jem.164.1.144", "volume": "164", "author": "JD Young", "year": "1986", "unstructured": "Young JD, Podack ER, Cohn ZA. Properties of a purified pore-forming protein (perforin 1) isolated from H2-restricted cytotoxic T cell granules. J Exp Med 1986; 164: 144\u2013155.", "journal-title": "J Exp Med"}, {"key": "25_CR24", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/S0952-7915(00)00094-7", "volume": "12", "author": "JA Trapani", "year": "2000", "unstructured": "Trapani JA, Davis J, Sutton VR, Smyth MJ. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 2000; 12: 323\u2013329.", "journal-title": "Curr Opin Immunol"}, {"key": "25_CR25", "doi-asserted-by": "publisher", "first-page": "1323", "DOI": "10.1084/jem.186.8.1323", "volume": "186", "author": "RV Talanian", "year": "1997", "unstructured": "Talanian RV, Yang X, Turbov J, et al. Granule-mediated killing pathways for granzyme B -initiated apoptosis. J Exp Med 1997; 186: 1323\u20131331.", "journal-title": "J Exp Med"}, {"key": "25_CR26", "first-page": "2810", "volume": "161", "author": "A San", "year": "1998", "unstructured": "San A, Haddad EK, Henkart PA. Caspase dependence of target cell damage induced by cytotoxic lymphocytes. J Immunol 1998; 161: 2810\u20132816.", "journal-title": "J Immunol"}, {"key": "25_CR27", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1016/S0167-4838(99)00282-4", "volume": "1477", "author": "CM Kam", "year": "2000", "unstructured": "Kam CM, Hudig D, Powers JC. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000; 1477: 307\u2013323.", "journal-title": "Biochim Biophys Acta"}, {"key": "25_CR28", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1006/smim.1997.0061", "volume": "9", "author": "SV Pena", "year": "1997", "unstructured": "Pena S V, Krensky AM. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 1997; 9: 117\u2013125.", "journal-title": "Semin Immunol"}, {"key": "25_CR29", "first-page": "2045", "volume": "83", "author": "HJ Gruss", "year": "1994", "unstructured": "Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045\u20132056.", "journal-title": "Blood"}, {"key": "25_CR30", "first-page": "2369", "volume": "155", "author": "MD Jumper", "year": "1995", "unstructured": "Jumper MD, Nishioka Y, Davis LS, Lipsky PE, Meek K. Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol 1995; 155: 2369\u20132378.", "journal-title": "J Immunol"}, {"key": "25_CR31", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/S0955-0674(99)80034-9", "volume": "11", "author": "A Ashkenazi", "year": "1999", "unstructured": "Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255\u2013260.", "journal-title": "Curr Opin Cell Biol"}, {"key": "25_CR32", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1084/jem.193.6.661", "volume": "193", "author": "MJ Smyth", "year": "2001", "unstructured": "Smyth MJ, Cretney E, Takeda K, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) Contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193: 661\u2013670.", "journal-title": "J Exp Med"}, {"key": "25_CR33", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1038/83416", "volume": "7", "author": "K Takeda", "year": "2001", "unstructured": "Takeda K, Hayakawa Y, Smyth MJ, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001; 7: 94\u2013100.", "journal-title": "Nat Med"}, {"key": "25_CR34", "doi-asserted-by": "publisher", "first-page": "969", "DOI": "10.1016/0092-8674(94)90375-1", "volume": "76", "author": "T Takahashi", "year": "1994", "unstructured": "Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by apoint mutation in the Fas ligand. Cell 1994; 76: 969\u2013976.", "journal-title": "Cell"}, {"key": "25_CR35", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1006/excr.2000.4840", "volume": "256", "author": "H Walczak", "year": "2000", "unstructured": "Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000; 256: 58\u201366.", "journal-title": "Exp Cell Res"}, {"key": "25_CR36", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1111/j.1749-6632.2000.tb05598.x", "volume": "926", "author": "K Abe", "year": "2000", "unstructured": "Abe K, Kurakin A, Mohseni-Maybodi M, Kay B, Khosravi-Far R. The complexity of TNF-related apoptosisinducing ligand. Ann NYAcad Sci 2000; 926: 52\u201363.", "journal-title": "Ann NYAcad Sci"}, {"key": "25_CR37", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1038/4779", "volume": "5", "author": "G Bossi", "year": "1999", "unstructured": "Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 1999; 5: 90\u201396.", "journal-title": "Nat Med"}, {"key": "25_CR38", "doi-asserted-by": "publisher", "first-page": "1777", "DOI": "10.1084/jem.182.6.1777", "volume": "182", "author": "N Kayagaki", "year": "1995", "unstructured": "Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182: 1777\u201317783.", "journal-title": "J Exp Med"}, {"key": "25_CR39", "doi-asserted-by": "publisher", "first-page": "155", "DOI": "10.1172/JCI6926", "volume": "104", "author": "A Ashkenazi", "year": "1999", "unstructured": "Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155\u2013162.", "journal-title": "J Clin Invest"}, {"key": "25_CR40", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1038/5517", "volume": "5", "author": "H Walczak", "year": "1999", "unstructured": "Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosisinducing ligand in vivo. Nat Med 1999; 5: 157\u201363.", "journal-title": "Nat Med"}, {"key": "25_CR41", "doi-asserted-by": "publisher", "first-page": "673", "DOI": "10.1016/1074-7613(95)90057-8", "volume": "3", "author": "SR Wiley", "year": "1995", "unstructured": "Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673\u2013682.", "journal-title": "Immunity"}, {"issue": "12", "key": "25_CR42", "first-page": "687", "volume": "271", "author": "RM Pitti", "year": "1996", "unstructured": "Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;271:12, 687\u201312, 690.", "journal-title": "J Biol Chem"}, {"key": "25_CR43", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1038/75045", "volume": "6", "author": "M Jo", "year": "2000", "unstructured": "Jo M, Kim TH, Seol DW, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 2000; 6: 564\u2013567.", "journal-title": "Nat Med"}, {"key": "25_CR44", "doi-asserted-by": "publisher", "first-page": "829", "DOI": "10.1146/annurev.immunol.17.1.829", "volume": "17", "author": "E Sebzda", "year": "1999", "unstructured": "Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Selection of the T cell repertoire. Annu Rev Immunol 1999; 17: 829\u2013874.", "journal-title": "Annu Rev Immunol"}, {"issue": "13", "key": "25_CR45", "first-page": "23", "volume": "6", "author": "VH Engelhard", "year": "1994", "unstructured": "Engelhard VH. Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 1994; 6: 13 23.", "journal-title": "Curr Opin Immunol"}, {"key": "25_CR46", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/0952-7915(94)90032-9", "volume": "6", "author": "O Rotzschke", "year": "1994", "unstructured": "Rotzschke O, Falk K. Origin, structure and motifs of naturally processed MHC class II ligands. Curr Opin Immunol 1994; 6: 45\u201351.", "journal-title": "Curr Opin Immunol"}, {"key": "25_CR47", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1126/science.290.5489.92", "volume": "290", "author": "A Lanzavecchia", "year": "2000", "unstructured": "Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290: 92\u201397.", "journal-title": "Science"}, {"key": "25_CR48", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1038/79734", "volume": "1", "author": "M Moser", "year": "2000", "unstructured": "Moser M, Murphy KM. Dendritic cell regulation of TH1\u2013TH2 development. Nat Immunol 2000; 1: 199\u2013205.", "journal-title": "Nat Immunol"}, {"key": "25_CR49", "doi-asserted-by": "publisher", "first-page": "1945", "DOI": "10.1084/jem.181.6.1945", "volume": "181", "author": "A Lanzavecchia", "year": "1995", "unstructured": "Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995; 181: 1945\u20131948.", "journal-title": "J Exp Med"}, {"key": "25_CR50", "doi-asserted-by": "publisher", "first-page": "628", "DOI": "10.1016/S0952-7915(96)80078-1", "volume": "8", "author": "PF Robbins", "year": "1996", "unstructured": "Robbins PF, Kawakami Y. Human tumor antigens recognized by T cells. Curr Opin Immunol 1996; 8: 628\u2013636.", "journal-title": "Curr Opin Immunol"}, {"key": "25_CR51", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1016/S0952-7915(96)80079-3", "volume": "8", "author": "ML Disis", "year": "1996", "unstructured": "Disis ML, Cheever MA. Oncogenic proteins as tumor antigens. Curr Opin Immunol 1996; 8: 637\u2013642.", "journal-title": "Curr Opin Immunol"}, {"key": "25_CR52", "doi-asserted-by": "publisher", "first-page": "673", "DOI": "10.1016/S1074-7613(00)80066-7", "volume": "10", "author": "RH Vonderheide", "year": "1999", "unstructured": "Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10: 673\u2013679.", "journal-title": "Immunity"}, {"key": "25_CR53", "first-page": "2756", "volume": "5", "author": "F Wang", "year": "1999", "unstructured": "Wang F, Bade E, Kuniyoshi C, et al. Phase I trial of a MART-1 peptide vaccine with incomplete Freund\u2019s adjuvant for resected high-risk melanoma. Clin Cancer Res 1999; 5: 2756\u20132765.", "journal-title": "Clin Cancer Res"}, {"key": "25_CR54", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1038/nm0196-52", "volume": "2", "author": "FJ Hsu", "year": "1996", "unstructured": "Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996; 2: 52\u201358.", "journal-title": "Nat Med"}, {"key": "25_CR55", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1097/00002371-200101000-00008", "volume": "24", "author": "R Lau", "year": "2001", "unstructured": "Lau R, Wang F, Jeffery G, et al. Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J Immunother 2001; 24: 66\u201378.", "journal-title": "J Immunother"}, {"key": "25_CR56", "first-page": "1549", "volume": "92", "author": "CM Rooney", "year": "1998", "unstructured": "Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549\u20131555.", "journal-title": "Blood"}, {"key": "25_CR57", "doi-asserted-by": "publisher", "first-page": "1038", "DOI": "10.1056/NEJM199510193331603", "volume": "333", "author": "EA Walter", "year": "1995", "unstructured": "Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellularimmunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038\u20131044.", "journal-title": "N Engl J Med"}, {"key": "25_CR58", "first-page": "1133", "volume": "89", "author": "A Choudhury", "year": "1997", "unstructured": "Choudhury A, Gaj ewski JL, Liang JC, et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1997; 89: 1133\u20131142.", "journal-title": "Blood"}, {"key": "25_CR59", "first-page": "549", "volume": "90", "author": "AA Cardoso", "year": "1997", "unstructured": "Cardoso AA, Seamon MS, Afonso HM, et al. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood 1997; 90: 549\u2013561.", "journal-title": "Blood"}, {"key": "25_CR60", "first-page": "1677", "volume": "92", "author": "T Mutis", "year": "1998", "unstructured": "Mutis T, Schrama E, Melief CJ, Goulmy E. CD8O-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens. Blood 1998; 92: 1677\u20131684.", "journal-title": "Blood"}, {"key": "25_CR61", "first-page": "1317", "volume": "96", "author": "R Stripecke", "year": "2000", "unstructured": "Stripecke R, Cardoso AA, Pepper KA, et al. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. Blood 2000; 96: 1317\u20131326.", "journal-title": "Blood"}, {"key": "25_CR62", "first-page": "4263", "volume": "94", "author": "K Dunussi-Joannopoulos", "year": "1999", "unstructured": "Dunussi-Joannopoulos K, Runyon K, Erickson J, Schaub RG, Hawley RG, Leonard JP. Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity. Blood 1999; 94: 4263\u20134273.", "journal-title": "Blood"}, {"key": "25_CR63", "doi-asserted-by": "publisher", "first-page": "1090", "DOI": "10.1038/nm1096-1090", "volume": "2", "author": "D Dilloo", "year": "1996", "unstructured": "Dilloo D, Bacon K, Holden W, et al. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med 1996; 2: 1090\u20131095.", "journal-title": "Nat Med"}, {"key": "25_CR64", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1126/science.274.5284.94", "volume": "274", "author": "JD Altman", "year": "1996", "unstructured": "Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94\u201396.", "journal-title": "Science"}, {"key": "25_CR65", "first-page": "365", "volume": "60", "author": "SJ Youde", "year": "2000", "unstructured": "Youde SJ, Dunbar PR, Evans EM, et al. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/ HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. Cancer Res 2000; 60: 365\u2013371.", "journal-title": "Cancer Res"}, {"key": "25_CR66", "first-page": "6292", "volume": "163", "author": "KH Lee", "year": "1999", "unstructured": "Lee KH, Wang E, Nielsen MB, et al. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol 1999; 163: 6292\u20136300.", "journal-title": "J Immunol"}, {"key": "25_CR67", "doi-asserted-by": "publisher", "first-page": "677", "DOI": "10.1038/9525", "volume": "5", "author": "PP Lee", "year": "1999", "unstructured": "Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999; 5: 677\u2013685.", "journal-title": "Nat Med"}, {"key": "25_CR68", "doi-asserted-by": "publisher", "first-page": "1018", "DOI": "10.1038/79526", "volume": "6", "author": "JJ Molldrem", "year": "2000", "unstructured": "Molldrem JJ, Lee PP, Wang C, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000; 6: 1018\u20131023.", "journal-title": "Nat Med"}, {"key": "25_CR69", "first-page": "2999", "volume": "94", "author": "L Gao", "year": "1999", "unstructured": "Gao L, Yang TH, Tourdot S, Sadovnikova E, Hasserjian R, Stauss HJ. Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graftversus-host disease. Blood 1999; 94: 2999\u20133006.", "journal-title": "Blood"}, {"key": "25_CR70", "first-page": "1525", "volume": "59", "author": "LD Anderson Jr.", "year": "1999", "unstructured": "Anderson LD, Jr., Petropoulos D, Everse LA, Mullen CA. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res 1999; 59: 1525\u20131530.", "journal-title": "Cancer Res"}, {"key": "25_CR71", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1126/science.6158759", "volume": "210", "author": "JL Sullivan", "year": "1980", "unstructured": "Sullivan JL, Byron KS, Brewster FE, Purtilo DT. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science 1980; 210: 543\u2013545.", "journal-title": "Science"}, {"key": "25_CR72", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1007/BF00917330", "volume": "6", "author": "F Merino", "year": "1986", "unstructured": "Merino F, Henle W, Ramirez-Duque P. Chronic active Epstein-Barr virus infection in patients with ChediakHigashi syndrome. J Clin Immunol 1986; 6: 299\u2013305.", "journal-title": "J Clin Immunol"}, {"issue": "553", "key": "25_CR73", "first-page": "555", "volume": "284", "author": "JC Roder", "year": "1980", "unstructured": "Roder JC, Haliotis T, Klein M, et al. A new immunodeficiency disorder in humans involving NK cells. Nature 1980; 284: 553 555.", "journal-title": "Nature"}, {"key": "25_CR74", "first-page": "555", "volume": "46", "author": "JC Roder", "year": "1982", "unstructured": "Roder JC, Haliotis T, Laing L, et al. Further studies of natural killer cell function in Chediak-Higashi patients. Immunology 1982; 46: 555\u2013560.", "journal-title": "Immunology"}, {"key": "25_CR75", "doi-asserted-by": "crossref", "first-page": "3549", "DOI": "10.4049/jimmunol.165.7.3549", "volume": "165", "author": "L Benoit", "year": "2000", "unstructured": "Benoit L, Wang X, Pabst HF, Dutz J, Tan R. Defective NK cell activation in X-linked lymphoproliferative disease. J Immunol 2000; 165: 3549\u20133553.", "journal-title": "J Immunol"}, {"key": "25_CR76", "doi-asserted-by": "publisher", "first-page": "1823", "DOI": "10.1084/jem.155.6.1823", "volume": "155", "author": "EA Grimm", "year": "1982", "unstructured": "Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823\u20131841.", "journal-title": "J Exp Med"}, {"issue": "287", "key": "25_CR77", "first-page": "298", "volume": "16", "author": "JV Teichmann", "year": "1992", "unstructured": "Teichmann JV, Ludwig WD, Thiel E. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor. Leuk Res 1992; 16: 287 298.", "journal-title": "Leuk Res"}, {"key": "25_CR78", "doi-asserted-by": "publisher", "first-page": "622", "DOI": "10.1038/284622a0", "volume": "284", "author": "JE Talmadge", "year": "1980", "unstructured": "Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of NK cells in tumour growth and metastasis in beige mice. Nature 1980; 284: 622\u2013624.", "journal-title": "Nature"}, {"issue": "13", "key": "25_CR79", "first-page": "S57", "volume": "12", "author": "L Uharek", "year": "1993", "unstructured": "Uharek L, Glass B, Gaska T, et al. Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model. Bone Marrow Transplant 1993; 12 (Supp13): S57\u201360.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR80", "doi-asserted-by": "publisher", "first-page": "1485", "DOI": "10.1056/NEJM198512053132327", "volume": "313", "author": "SA Rosenberg", "year": "1985", "unstructured": "Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485\u20131492.", "journal-title": "N Engl J Med"}, {"key": "25_CR81", "doi-asserted-by": "crossref", "first-page": "1233", "DOI": "10.1200/JCO.1991.9.7.1233", "volume": "9", "author": "RO Dillman", "year": "1991", "unstructured": "Dillman RO, Oldham RK, Tauer KW, et al. Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial. J Clin Oncol 1991; 9: 1233\u20131240.", "journal-title": "J Clin Oncol"}, {"key": "25_CR82", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1097/00002371-199204000-00005", "volume": "11", "author": "KA Foon", "year": "1992", "unstructured": "Foon KA, Walther PJ, Bernstein ZP, et al. Renal cell carcinoma treated with continuous-infusion interleukin2 with ex vivo-activated killer cells. Jlmmunother 1992; 11: 184\u2013190.", "journal-title": "Jlmmunother"}, {"issue": "218", "key": "25_CR83", "first-page": "223", "volume": "19", "author": "I Haruta", "year": "1996", "unstructured": "Haruta I, Yamauchi K, Aruga A, et al. Analytical study of the clinical response to two distinct adoptive immunotherapies for advanced hepatocellular carcinoma: comparison between LAK cell and CTL therapy. JImmunother Emphasis Tumor Immunol 1996; 19: 218 223.", "journal-title": "JImmunother Emphasis Tumor Immunol"}, {"key": "25_CR84", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1007/BF00177476", "volume": "27", "author": "SK Sankhla", "year": "1996", "unstructured": "Sankhla SK, Nadkarni JS, Bhagwati SN. Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors. J Neurooncol 1996; 27: 133\u2013140.", "journal-title": "J Neurooncol"}, {"key": "25_CR85", "first-page": "622", "volume": "85", "author": "SA Rosenberg", "year": "1993", "unstructured": "Rosenberg SA, Lotze MT, Yang JC, et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 1993; 85: 622\u2013632.", "journal-title": "Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst"}, {"key": "25_CR86", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/S0169-5002(99)00082-3", "volume": "26", "author": "T Yano", "year": "1999", "unstructured": "Yano T, Sugio K, Yamazaki K, et al. Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancer. Lung Cancer 1999; 26: 143\u2013148.", "journal-title": "Lung Cancer"}, {"key": "25_CR87", "doi-asserted-by": "crossref", "first-page": "694", "DOI": "10.1200/JCO.1991.9.4.694", "volume": "9", "author": "JP Siegel", "year": "1991", "unstructured": "Siegel JP, Puri RK. Interleukin-2 toxicity. J Clin Oncol 1991; 9: 694\u2013704.", "journal-title": "J Clin Oncol"}, {"key": "25_CR88", "doi-asserted-by": "publisher", "first-page": "875", "DOI": "10.1146/annurev.immunol.17.1.875", "volume": "17", "author": "EO Long", "year": "1999", "unstructured": "Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999; 17: 875\u2013904.", "journal-title": "Annu Rev Immunol"}, {"key": "25_CR89", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1146/annurev.immunol.16.1.359", "volume": "16", "author": "LL Lanier", "year": "1998", "unstructured": "Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359\u2013393.", "journal-title": "Annu Rev Immunol"}, {"key": "25_CR90", "doi-asserted-by": "publisher", "first-page": "1745", "DOI": "10.1084/jem.162.6.1745", "volume": "162", "author": "HG Ljunggren", "year": "1985", "unstructured": "Ljunggren HG, Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985; 162: 1745\u20131759.", "journal-title": "J Exp Med"}, {"key": "25_CR91", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1016/S0952-7915(00)00092-3", "volume": "12", "author": "I Tamir", "year": "2000", "unstructured": "Tamir I, Dal Porto JM, Cambier JC. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction. Curr Opin Immunol 2000; 12: 307\u2013315.", "journal-title": "Curr Opin Immunol"}, {"key": "25_CR92", "first-page": "505", "volume": "14", "author": "LR Rohrschneider", "year": "2000", "unstructured": "Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM. Structure, function, and biology of SHIP proteins. Genes Dev 2000; 14: 505\u2013520.", "journal-title": "Genes Dev"}, {"key": "25_CR93", "doi-asserted-by": "publisher", "first-page": "1259", "DOI": "10.1084/jem.191.8.1259", "volume": "191", "author": "LL Lanier", "year": "2000", "unstructured": "Lanier LL. Turning on natural killer cells. J Exp Med 2000; 191: 1259\u20131262.", "journal-title": "J Exp Med"}, {"key": "25_CR94", "doi-asserted-by": "publisher", "first-page": "730", "DOI": "10.1126/science.285.5428.730", "volume": "285", "author": "J Wu", "year": "1999", "unstructured": "Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999; 285: 730\u2013732.", "journal-title": "Science"}, {"key": "25_CR95", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/S0198-8859(99)00170-6", "volume": "61", "author": "H Nakajima", "year": "2000", "unstructured": "Nakajima H, Colonna M. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. Hum Immunol 2000; 61: 39\u201343.", "journal-title": "Hum Immunol"}, {"key": "25_CR96", "doi-asserted-by": "publisher", "first-page": "1076", "DOI": "10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y", "volume": "31", "author": "D Pende", "year": "2001", "unstructured": "Pende D, Cantoni C, Rivera P, et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001; 31: 1076\u20131086.", "journal-title": "Eur J Immunol"}, {"key": "25_CR97", "doi-asserted-by": "publisher", "first-page": "1839", "DOI": "10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E", "volume": "28", "author": "IH Westgaard", "year": "1998", "unstructured": "Westgaard IH, Berg SF, Orstavik S, Fossum S, Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol 1998; 28: 1839\u20131846.", "journal-title": "Eur J Immunol"}, {"key": "25_CR98", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1007/s002510050421", "volume": "48", "author": "KL Mcqueen", "year": "1998", "unstructured": "McQueen KL, Freeman JD, Takei F, Mager DL. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics 1998; 48: 174\u2013183.", "journal-title": "Immunogenetics"}, {"key": "25_CR99", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1002/jlb.66.1.165", "volume": "66", "author": "P Gosselin", "year": "1999", "unstructured": "Gosselin P, Mason LH, Willette-Brown J, Ortaldo JR, McVicar DW, Anderson SK. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol 1999; 66: 165\u2013171.", "journal-title": "J Leukoc Biol"}, {"issue": "2433", "key": "25_CR100", "first-page": "1995", "volume": "25", "author": "C Chang", "year": "2437", "unstructured": "Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995; 25: 2433 2437.", "journal-title": "Eur J Immunol"}, {"key": "25_CR101", "doi-asserted-by": "publisher", "first-page": "3236", "DOI": "10.1002/eji.1830271222", "volume": "27", "author": "RE Vance", "year": "1997", "unstructured": "Vance RE, Tanamachi DM, Hanke T, Raulet DH. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol 1997; 27: 3236\u20133241.", "journal-title": "Eur J Immunol"}, {"key": "25_CR102", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1084/jem.188.5.973", "volume": "188", "author": "Z Kurepa", "year": "1998", "unstructured": "Kurepa Z, Hasemann CA, Forman J. Qa-lb binds conserved class I leader peptides derived from several mammalian species. J Exp Med 1998; 188: 973\u2013978.", "journal-title": "J Exp Med"}, {"key": "25_CR103", "doi-asserted-by": "publisher", "first-page": "1841", "DOI": "10.1084/jem.188.10.1841", "volume": "188", "author": "RE Vance", "year": "1998", "unstructured": "Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 1998; 188: 1841\u20131848.", "journal-title": "J Exp Med"}, {"key": "25_CR104", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1038/35869", "volume": "391", "author": "VM Braud", "year": "1998", "unstructured": "Braud VM, Allan DS, O\u2019Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795\u2013799.", "journal-title": "Nature"}, {"key": "25_CR105", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1007/s002510050420", "volume": "48", "author": "J Glienke", "year": "1998", "unstructured": "Glienke J, Sobanov Y, Brostjan C, et al. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 1998; 48: 163\u2013173.", "journal-title": "Immunogenetics"}, {"key": "25_CR106", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1126/science.285.5428.727", "volume": "285", "author": "S Bauer", "year": "1999", "unstructured": "Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727\u2013729.", "journal-title": "Science"}, {"issue": "12", "key": "25_CR107", "first-page": "445", "volume": "93", "author": "V Groh", "year": "1996", "unstructured": "Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996;93:12, 445\u201312, 450.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "25_CR108", "doi-asserted-by": "publisher", "first-page": "6879", "DOI": "10.1073/pnas.96.12.6879", "volume": "96", "author": "V Groh", "year": "1999", "unstructured": "Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 1999; 96: 6879\u20136884.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "25_CR109", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1038/77793", "volume": "1", "author": "A Diefenbach", "year": "2000", "unstructured": "Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1: 119\u2013126.", "journal-title": "Nat Immunol"}, {"key": "25_CR110", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1016/S1074-7613(00)80222-8", "volume": "12", "author": "A Cerwenka", "year": "2000", "unstructured": "Cerwenka A, Bakker AB, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12: 721\u2013727.", "journal-title": "Immunity"}, {"key": "25_CR111", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1146/annurev.immunol.19.1.197", "volume": "19", "author": "A Moretta", "year": "2001", "unstructured": "Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197\u2013223.", "journal-title": "Annu Rev Immunol"}, {"key": "25_CR112", "doi-asserted-by": "publisher", "first-page": "1656", "DOI": "10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1", "volume": "29", "author": "S Sivori", "year": "1999", "unstructured": "Sivori S, Pende D, Bottino C, et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999; 29: 1656\u20131666.", "journal-title": "Eur J Immunol"}, {"key": "25_CR113", "doi-asserted-by": "publisher", "first-page": "1129", "DOI": "10.1084/jem.186.7.1129", "volume": "186", "author": "S Sivori", "year": "1997", "unstructured": "Sivori S, Vitale M, Morelli L, et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med 1997; 186: 1129\u20131136.", "journal-title": "J Exp Med"}, {"key": "25_CR114", "doi-asserted-by": "publisher", "first-page": "953", "DOI": "10.1084/jem.188.5.953", "volume": "188", "author": "A Pessino", "year": "1998", "unstructured": "Pessino A, Sivori S, Bottino C, et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998; 188: 953\u2013960.", "journal-title": "J Exp Med"}, {"key": "25_CR115", "doi-asserted-by": "publisher", "first-page": "1505", "DOI": "10.1084/jem.190.10.1505", "volume": "190", "author": "D Pende", "year": "1999", "unstructured": "Pende D, Parolini S, Pessino A, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999; 190: 1505\u20131516.", "journal-title": "J Exp Med"}, {"key": "25_CR116", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1084/jem.189.5.787", "volume": "189", "author": "C Cantoni", "year": "1999", "unstructured": "Cantoni C, Bottino C, Vitale M, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999; 189: 787\u2013796.", "journal-title": "J Exp Med"}, {"key": "25_CR117", "doi-asserted-by": "publisher", "first-page": "2065", "DOI": "10.1084/jem.187.12.2065", "volume": "187", "author": "M Vitale", "year": "1998", "unstructured": "Vitale M, Bottino C, Sivori S, et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor celllysis. J Exp Med 1998; 187: 2065\u20132072.", "journal-title": "J Exp Med"}, {"key": "25_CR118", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4", "volume": "31", "author": "M Vitale", "year": "2001", "unstructured": "Vitale M, Falco M, Castriconi R, et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol 2001; 31: 233\u2013242.", "journal-title": "Eur J Immunol"}, {"key": "25_CR119", "doi-asserted-by": "publisher", "first-page": "1835", "DOI": "10.1172/JCI1268", "volume": "101", "author": "O Asai", "year": "1998", "unstructured": "Asai O, Longo DL, Tian ZG, et al. Suppression of graft-versus-host disease and amplification of graftversus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998; 101: 1835\u20131842.", "journal-title": "J Clin Invest"}, {"key": "25_CR120", "doi-asserted-by": "publisher", "first-page": "1186", "DOI": "10.1056/NEJM199810223391702", "volume": "339", "author": "F Aversa", "year": "1998", "unstructured": "Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186\u20131193.", "journal-title": "N Engl J Med"}, {"key": "25_CR121", "first-page": "333", "volume": "94", "author": "L Ruggeri", "year": "1999", "unstructured": "Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333\u2013339.", "journal-title": "Blood"}, {"key": "25_CR122", "first-page": "96", "volume": "479", "author": "L Ruggeri", "year": "2000", "unstructured": "Ruggeri L, Capanni M, Urbani E, et al. KIR epitope incompatibility in the GvH direction predicts control of leukemia relapse after mismatched hematopoietic transplantation. Blood 2000; 96: 479a.", "journal-title": "Blood"}, {"key": "25_CR123", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1146/annurev.immunol.15.1.535", "volume": "15", "author": "A Bendelac", "year": "1997", "unstructured": "Bendelac A, Rivera MN, Park SH, RoarkJH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997; 15: 535\u2013562.", "journal-title": "Annu Rev Immunol"}, {"key": "25_CR124", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1006/cimm.1993.1159", "volume": "149", "author": "H Watanabe", "year": "1993", "unstructured": "Watanabe H, liai T, Kimura M, et al. Characterization of intermediate TCR cells in the liver of mice with respect to their unique IL-2R expression. Cell Immunol 1993; 149: 331\u2013342.", "journal-title": "Cell Immunol"}, {"key": "25_CR125", "first-page": "6410", "volume": "162", "author": "G Eberl", "year": "1999", "unstructured": "Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1ddependent and CD1d-independent NK T cells. J Immunol 1999; 162: 6410\u2013641.", "journal-title": "J Immunol"}, {"key": "25_CR126", "first-page": "1158", "volume": "160", "author": "JR Ortaldo", "year": "1998", "unstructured": "Ortaldo JR, Winkler-Pickett R, Mason AT, Mason LH. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J Immunol 1998; 160: 1158\u20131165.", "journal-title": "J Immunol"}, {"key": "25_CR127", "doi-asserted-by": "publisher", "first-page": "5445", "DOI": "10.1016/S0091-6749(99)70160-0", "volume": "103", "author": "A Sakamoto", "year": "1999", "unstructured": "Sakamoto A, Oishi Y, Kurasawa K, Kita Y, Saito Y, Iwamoto I. Characteristics of T-cell receptor Valpha24JalphaQ T cells, a human counterpart of murine NK1 T cells, from normal subjects. J Allergy Clin Immunol 1999; 103: 5445\u2013451.", "journal-title": "J Allergy Clin Immunol"}, {"key": "25_CR128", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1016/S0167-5699(00)01735-7", "volume": "21", "author": "DI Godfrey", "year": "2000", "unstructured": "Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573\u2013583.", "journal-title": "Immunol Today"}, {"key": "25_CR129", "doi-asserted-by": "publisher", "first-page": "1895", "DOI": "10.1084/jem.191.11.1895", "volume": "191", "author": "K Benlagha", "year": "2000", "unstructured": "Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000; 191: 1895\u20131903.", "journal-title": "J Exp Med"}, {"key": "25_CR130", "doi-asserted-by": "publisher", "first-page": "1626", "DOI": "10.1126/science.278.5343.1626", "volume": "278", "author": "T Kawano", "year": "1997", "unstructured": "Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of valphal4 NKT cells by glycosylceramides. Science 1997; 278: 1626\u20131629.", "journal-title": "Science"}, {"key": "25_CR131", "doi-asserted-by": "publisher", "first-page": "1491", "DOI": "10.1093/intimm/10.10.1491", "volume": "10", "author": "K Hammond", "year": "1998", "unstructured": "Hammond K, Cain W, van Driel I, Godfrey D. Three day neonatal thymectomy selectively depletes NK1.1+ T cells. Int Immunol 1998; 10: 1491\u20131499.", "journal-title": "Int Immunol"}, {"key": "25_CR132", "doi-asserted-by": "crossref", "first-page": "2412", "DOI": "10.4049/jimmunol.164.5.2412", "volume": "164", "author": "MC Coles", "year": "2000", "unstructured": "Coles MC, Raulet DH. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol 2000; 164: 2412\u20132418.", "journal-title": "J Immunol"}, {"key": "25_CR133", "doi-asserted-by": "publisher", "first-page": "3768", "DOI": "10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.0.CO;2-G", "volume": "29", "author": "KJ Hammond", "year": "1999", "unstructured": "Hammond KJ, Pelikan SB, Crowe NY, et al. NKT cells are phenotypically and functionally diverse. Eur J Immunol 1999; 29: 3768\u20133781.", "journal-title": "Eur J Immunol"}, {"key": "25_CR134", "first-page": "5338", "volume": "163", "author": "D Zeng", "year": "1999", "unstructured": "Zeng D, Gazit G, Dejbakhsh-Jones S, et al. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. J Immunol 1999; 163: 5338\u20135345.", "journal-title": "J Immunol"}, {"key": "25_CR135", "doi-asserted-by": "publisher", "first-page": "2300", "DOI": "10.1002/1521-4141(2000)30:8<2300::AID-IMMU2300>3.0.CO;2-2", "volume": "30", "author": "M Emoto", "year": "2000", "unstructured": "Emoto M, Zerrahn J, Miyamoto M, Perarnau B, Kaufmann SH. Phenotypic characterization of CD8(+)NKT cells. Eur J Immunol 2000; 30: 2300\u20132311.", "journal-title": "Eur J Immunol"}, {"key": "25_CR136", "doi-asserted-by": "publisher", "first-page": "1763", "DOI": "10.1084/jem.177.6.1763", "volume": "177", "author": "P Dellabona", "year": "1993", "unstructured": "Dellabona P, Casorati G, Friedli B, et al. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4\u20138- subset. J Exp Med 1993; 177: 1763\u20131771.", "journal-title": "J Exp Med"}, {"key": "25_CR137", "doi-asserted-by": "crossref", "first-page": "1659", "DOI": "10.4049/jimmunol.165.3.1659", "volume": "165", "author": "S Ishihara", "year": "2000", "unstructured": "Ishihara S, Nieda M, Kitayama J, et al. Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3\u2013CD56+ NK cells in vitro. J Immunol 2000; 165: 1659\u20131664.", "journal-title": "J Immunol"}, {"key": "25_CR138", "first-page": "5862", "volume": "159", "author": "C Prussin", "year": "1997", "unstructured": "Prussin C, Foster B. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol 1997; 159: 5862\u20135870.", "journal-title": "J Immunol"}, {"key": "25_CR139", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1046/j.1365-2567.1999.00920.x", "volume": "98", "author": "HJ Vliet Van Der", "year": "1999", "unstructured": "Van Der Vliet HJ, Nishi N, Koezuka Y, et al. Effects of alpha-galactosylceramide (KRN7000), interleukin12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbetal l+ T cells. Immunology 1999; 98: 557\u2013563.", "journal-title": "Immunology"}, {"key": "25_CR140", "doi-asserted-by": "crossref", "first-page": "4458", "DOI": "10.4049/jimmunol.164.9.4458", "volume": "164", "author": "T Takahashi", "year": "2000", "unstructured": "Takahashi T, Nieda M, Koezuka Y, et al. Analysis of human V alpha 24+ CD4+ NKT cells activated by alphaglycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2000; 164: 4458\u20134464.", "journal-title": "J Immunol"}, {"key": "25_CR141", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1016/S0022-1759(00)00272-6", "volume": "247", "author": "HJ Vliet", "year": "2001", "unstructured": "van der Vliet HJ, Nishi N, Koezuka Y, et al. Potent expansion of human natural killer T cells using alphagalactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Methods 2001; 247: 61\u201372.", "journal-title": "J Immunol Methods"}, {"key": "25_CR142", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1016/S1074-7613(00)80174-0", "volume": "12", "author": "JE Gumperz", "year": "2000", "unstructured": "Gumperz JE, Roy C, Makowska A, et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000; 12: 211\u2013221.", "journal-title": "Immunity"}, {"key": "25_CR143", "first-page": "4091", "volume": "163", "author": "G Eberl", "year": "1999", "unstructured": "Eberl G, Lowin-Kropf B, MacDonald HR. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. Jlmmunol 1999; 163: 4091\u20134094.", "journal-title": "Jlmmunol"}, {"key": "25_CR144", "first-page": "2387", "volume": "163", "author": "I Toura", "year": "1999", "unstructured": "Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol 1999; 163: 2387\u20132391.", "journal-title": "J Immunol"}, {"key": "25_CR145", "doi-asserted-by": "publisher", "first-page": "1623", "DOI": "10.1126/science.278.5343.1623", "volume": "278", "author": "J Cui", "year": "1997", "unstructured": "Cui J, Shin T, Kawano T, et al. Requirement for Valphal4 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623\u20131626.", "journal-title": "Science"}, {"key": "25_CR146", "doi-asserted-by": "publisher", "first-page": "985", "DOI": "10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E", "volume": "30", "author": "G Eberl", "year": "2000", "unstructured": "Eberl G, MacDonald HR. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000; 30: 985\u2013992.", "journal-title": "Eur J Immunol"}, {"key": "25_CR147", "first-page": "4647", "volume": "163", "author": "C Carnaud", "year": "1999", "unstructured": "Carnaud C, Lee D, Donnars O, et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647\u20134650.", "journal-title": "J Immunol"}, {"key": "25_CR148", "first-page": "867", "volume": "188", "author": "M Exley", "year": "1998", "unstructured": "Exley M, Porcelli S, Furman M, Garcia J, Balk S. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 1998; 188: 867\u2013876.", "journal-title": "J alpha Q T cell receptor alpha chains. J Exp Med"}, {"issue": "229", "key": "25_CR149", "first-page": "234", "volume": "99", "author": "A Nicol", "year": "2000", "unstructured": "Nicol A, Nieda M, Koezuka Y, et al. Human invariant valpha24+ natural killer T cells activated by alphagalactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. Immunology 2000; 99: 229 234.", "journal-title": "Immunology"}, {"key": "25_CR150", "first-page": "4846", "volume": "158", "author": "K Tamada", "year": "1997", "unstructured": "Tamada K, Harada M, Abe K, et al. Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. J Immunol 1997; 158: 4846\u20134854.", "journal-title": "J Immunol"}, {"key": "25_CR151", "doi-asserted-by": "publisher", "first-page": "515", "DOI": "10.1038/82771", "volume": "1", "author": "M Terabe", "year": "2000", "unstructured": "Terabe M, Matsui S, Noben-Trauth N, et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000; 1: 515\u2013520.", "journal-title": "Nat Immunol"}, {"key": "25_CR152", "doi-asserted-by": "publisher", "first-page": "1073", "DOI": "10.1084/jem.189.7.1073", "volume": "189", "author": "D Zeng", "year": "1999", "unstructured": "Zeng D, Lewis D, Dejbakhsh-Jones S, et al. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 1073\u20131081.", "journal-title": "J Exp Med"}, {"key": "25_CR153", "doi-asserted-by": "publisher", "first-page": "248", "DOI": "10.1046/j.1365-2567.1998.00573.x", "volume": "95", "author": "Y Onoe", "year": "1998", "unstructured": "Onoe Y, Harada M, Tamada K, et al. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease. Immunology 1998; 95: 248\u2013256.", "journal-title": "Immunology"}, {"key": "25_CR154", "doi-asserted-by": "publisher", "first-page": "352", "DOI": "10.1016/0008-8749(90)90260-X", "volume": "131", "author": "DM Baume", "year": "1990", "unstructured": "Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol 1990; 131: 352\u2013365.", "journal-title": "Cell Immunol"}, {"key": "25_CR155", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1111/j.1365-2141.1994.tb08297.x", "volume": "87", "author": "I Schmidt-Wolf", "year": "1994", "unstructured": "Schmidt-Wolf I, Lefterova P, Johnston V, Jihn D, Blume K, Negrin R. Propagation of large number of T cells with natural killer cell markers. Br J Haematol 1994; 87: 453\u2013458.", "journal-title": "Br J Haematol"}, {"key": "25_CR156", "first-page": "1673", "volume": "21", "author": "IG Schmidt-Wolf", "year": "1993", "unstructured": "Schmidt-Wolf IG, Lefterova P, Mehta BA, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol 1993; 21: 1673\u20131679.", "journal-title": "Exp Hematol"}, {"key": "25_CR157", "unstructured": "Schmidt-Wolf IGH, Negrin RS, Kiem HP, Blume KG, Weissman IL. Use of a S CID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent anti-tumor activity. J Exp Med 1991; 139\u2013149.", "DOI": "10.1084/jem.174.1.139", "doi-asserted-by": "crossref"}, {"key": "25_CR158", "first-page": "1687", "volume": "153", "author": "PH Lu", "year": "1994", "unstructured": "Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 1994; 153: 1687\u20131696.", "journal-title": "J Immunol"}, {"key": "25_CR159", "doi-asserted-by": "publisher", "first-page": "629", "DOI": "10.1007/s002620000148", "volume": "49", "author": "RD Lopez", "year": "2001", "unstructured": "Lopez RD, Waller EK, Lu PH, Negrin RS. CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells. Cancer Immunol Immunother 2001; 49: 629\u2013640.", "journal-title": "Cancer Immunol Immunother"}, {"key": "25_CR160", "doi-asserted-by": "publisher", "first-page": "1385", "DOI": "10.1006/cyto.2000.0733", "volume": "12", "author": "B Zoll", "year": "2000", "unstructured": "Zoll B, Lefterova P, Ebert O, Huhn D, Von Ruecker A, Schmidt-Wolf IG. Modulation of cell surface markers on NK-like T lymphocytes by using IL- 2, IL-7 or IL-12 in vitro stimulation. Cytokine 2000; 12: 1385\u20131390.", "journal-title": "Cytokine"}, {"key": "25_CR161", "first-page": "3318", "volume": "92", "author": "C Hoyle", "year": "1998", "unstructured": "Hoyle C, Bangs CD, Chang P, Janek O, Mehta B, Negrin RS. Expansion of philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemia patients: in vitro an in vivo efficacy in severe combined immunodeficiency disease mice. Blood 1998; 92: 3318\u20133327.", "journal-title": "Blood"}, {"key": "25_CR162", "first-page": "216", "volume": "7", "author": "JC Alvarnas", "year": "2001", "unstructured": "Alvarnas JC, Linn YC, Hope EG, Negrin RS. Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 2001; 7: 216\u2013222.", "journal-title": "Transplant"}, {"key": "25_CR163", "first-page": "3493", "volume": "86", "author": "BA Mehta", "year": "1995", "unstructured": "Mehta BA, Schmidt-Wolf IG, Weissman IL, Negrin RS. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. Blood 1995; 86: 3493\u20133499.", "journal-title": "Blood"}, {"issue": "97", "key": "25_CR164", "first-page": "2923", "volume": "2001", "author": "J Baker", "year": "2931", "unstructured": "Baker J, Verneris MR, Ito M, Shizuru JA, Negrin RS. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood 2001; 97: 2923 2931.", "journal-title": "Blood"}, {"key": "25_CR165", "doi-asserted-by": "publisher", "first-page": "532", "DOI": "10.1016/S1083-8791(01)70014-6", "volume": "10", "author": "MR Verneris", "year": "2001", "unstructured": "Verneris MR, Ito M, Baker J, Arshi A, Negrin RS. Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+NK-T cells in the treatment of lymphoma. Biol Blood Marrow Transplant 2001; 10: 532\u2013542.", "journal-title": "Biol Blood Marrow Transplant"}, {"key": "25_CR166", "first-page": "3684", "volume": "163", "author": "JC Zeller", "year": "1999", "unstructured": "Zeller JC, Panoskaltsis-Mortari A, Murphy WJ, et al. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL- 10 and TGF-beta. Jlmmunol 1999; 163: 3684\u20133691.", "journal-title": "Jlmmunol"}, {"key": "25_CR167", "doi-asserted-by": "publisher", "first-page": "2126", "DOI": "10.1172/JCI4992", "volume": "102", "author": "YG Yang", "year": "1998", "unstructured": "Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest 1998; 102: 2126\u20132135.", "journal-title": "J Clin Invest"}, {"key": "25_CR168", "doi-asserted-by": "publisher", "first-page": "802", "DOI": "10.1016/S0140-6736(00)02654-4", "volume": "356", "author": "T Takayama", "year": "2000", "unstructured": "Takayama T, Sekine T, Makuuchi M, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 356: 802\u2013807.", "journal-title": "Lancet"}, {"key": "25_CR169", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1146/annurev.immunol.14.1.511", "volume": "14", "author": "YH Chien", "year": "1996", "unstructured": "Chien YH, Jores R, Crowley MP. Recognition by gamma/delta T cells. Ann Rev Immunol 1996; 14: 511\u2013532.", "journal-title": "Ann Rev Immunol"}, {"issue": "323", "key": "25_CR170", "first-page": "328", "volume": "179", "author": "EP Rock", "year": "1994", "unstructured": "Rock EP, Sibbald PR, Davis MM, Chien YH. CDR3 length in antigen-specific immune receptors. J Exp Med 1994; 179: 323 328.", "journal-title": "J Exp Med"}, {"key": "25_CR171", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/S0065-2776(08)60400-9", "volume": "71", "author": "W Born", "year": "1999", "unstructured": "Born W, Cady C, Jones-Carson J, Mukasa A, Lahn M, O\u2019Brien R Immunoregulatory functions of gamma delta T cells. Adv Immunol 1999; 71: 77\u2013144.", "journal-title": "Adv Immunol"}, {"issue": "737", "key": "25_CR172", "first-page": "738", "volume": "340", "author": "V Kunzmann", "year": "1999", "unstructured": "Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999; 340: 737, 738.", "journal-title": "N Engl J Med"}, {"key": "25_CR173", "doi-asserted-by": "publisher", "first-page": "530", "DOI": "10.1046/j.1365-2141.1998.00976.x", "volume": "103", "author": "MV Dhodapkar", "year": "1998", "unstructured": "Dhodapkar MV, Singh J, Mehta J, et al. Anti-myeloma activity of pamidronate in vivo. Br J Haematol 1998; 103: 530\u2013532.", "journal-title": "Br J Haematol"}, {"key": "25_CR174", "first-page": "384", "volume": "96", "author": "V Kunzmann", "year": "2000", "unstructured": "Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96: 384\u2013392.", "journal-title": "Blood"}, {"key": "25_CR175", "doi-asserted-by": "publisher", "first-page": "1737", "DOI": "10.1126/science.279.5357.1737", "volume": "279", "author": "V Groh", "year": "1998", "unstructured": "Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998; 279: 1737\u20131740.", "journal-title": "Science"}, {"key": "25_CR176", "first-page": "863", "volume": "9", "author": "M Duval", "year": "1995", "unstructured": "Duval M, Yotnda P, Bensussan A, et al. Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia. Leukemia 1995; 9: 863\u2013868.", "journal-title": "Leukemia"}, {"key": "25_CR177", "doi-asserted-by": "publisher", "first-page": "3368", "DOI": "10.1002/eji.1830271236", "volume": "27", "author": "P Fisch", "year": "1997", "unstructured": "Fisch P, Meuer E, Pende D, et al. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Eur Jlmmunol 1997; 27: 3368\u20133379.", "journal-title": "Eur Jlmmunol"}, {"key": "25_CR178", "first-page": "633", "volume": "3", "author": "Y Fujimiya", "year": "1997", "unstructured": "Fujimiya Y, Suzuki Y, Katakura R, et al. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients. Clin Cancer Res 1997; 3: 633\u2013643.", "journal-title": "Clin Cancer Res"}, {"key": "25_CR179", "doi-asserted-by": "publisher", "first-page": "709", "DOI": "10.1002/(SICI)1097-0215(19990301)80:5<709::AID-IJC14>3.0.CO;2-R", "volume": "80", "author": "AD Laad", "year": "1999", "unstructured": "Laad AD, Thomas ML, Fakih AR, Chiplunkar S V. Human gamma delta T cells recognize heat shock protein-60 on oral tumor cells. Int J Cancer 1999; 80: 709\u2013714.", "journal-title": "Int J Cancer"}, {"key": "25_CR180", "doi-asserted-by": "publisher", "first-page": "369", "DOI": "10.1111/1523-1747.ep12499808", "volume": "98", "author": "H Bachelez", "year": "1992", "unstructured": "Bachelez H, Flageul B, Degos L, Boumsell L, Bensussan A. TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomas. J Invest Dermatol 1992; 98: 369\u2013374.", "journal-title": "J Invest Dermatol"}, {"key": "25_CR181", "doi-asserted-by": "publisher", "first-page": "68", "DOI": "10.1111/j.1442-2042.1997.tb00143.x", "volume": "4", "author": "S Honda", "year": "1997", "unstructured": "Honda S, Sakamoto Y, Fujime M, Kitagawa R. Immunohistochemical study of tumor-infiltrating lymphocytes before and after intravesical bacillus Calmette-Gu\u00e9rin treatment for superficial bladder cancer. Int J Urol 1997; 4: 68\u201373.", "journal-title": "Int J Urol"}, {"key": "25_CR182", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1111/j.1365-2249.1993.tb08198.x", "volume": "93", "author": "J Kitayama", "year": "1993", "unstructured": "Kitayama J, Atomi Y, Nagawa H, et al. Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer. Clin Exp Immunol 1993; 93: 442\u2013447.", "journal-title": "Clin Exp Immunol"}, {"key": "25_CR183", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1046/j.1464-410X.1997.00408.x", "volume": "80", "author": "D Kowalczyk", "year": "1997", "unstructured": "Kowalczyk D, Skorupski W, Kwias Z, Nowak J. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma. Br J Urol 1997; 80: 543\u2013547.", "journal-title": "Br J Urol"}, {"key": "25_CR184", "first-page": "8451", "volume": "70", "author": "G Knowles", "year": "1996", "unstructured": "Knowles G, O\u2019Neil BW, Campo MS. Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol 1996; 70: 8451\u20138458.", "journal-title": "J Virol"}, {"key": "25_CR185", "first-page": "2095", "volume": "8", "author": "JC Kluin-Nelemans", "year": "1994", "unstructured": "Kluin-Nelemans JC, Kester MG, Oving I, Cluitmans FH, Willemze R, Falkenburg JH. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia. Leukemia 1994; 8: 2095\u20132101.", "journal-title": "Leukemia"}, {"key": "25_CR186", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1111/j.1365-2249.1995.tb06651.x", "volume": "102", "author": "N Watanabe", "year": "1995", "unstructured": "Watanabe N, Hizuta A, Tanaka N, Orita K. Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin Exp Immunol 1995; 102: 167\u2013173.", "journal-title": "Clin Exp Immunol"}, {"key": "25_CR187", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.3109/08820139509066861", "volume": "24", "author": "X Zhao", "year": "1995", "unstructured": "Zhao X, Wei YQ, Kariya Y, Teshigawara K, Uchida A. Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation. Immunol Invest 1995; 24: 607\u2013618.", "journal-title": "Immunol Invest"}, {"key": "25_CR188", "first-page": "242", "volume": "163", "author": "N Seo", "year": "1999", "unstructured": "Seo N, Tokura Y, Takigawa M, Egawa K. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 1999; 163: 242\u2013249.", "journal-title": "J Immunol"}, {"key": "25_CR189", "first-page": "249", "volume": "10", "author": "M Viale", "year": "1992", "unstructured": "Viale M, Ferrini S, Bacigalupo A. TCR gamma/delta positive lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 249\u2013253.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR190", "first-page": "741", "volume": "14", "author": "M Yabe", "year": "1994", "unstructured": "Yabe M, Yabe H, Hattori K, et al. Transition of T cell receptor gamma/delta expressing double negative (CD4/CD8-) lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 741\u2013746.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR191", "first-page": "243", "volume": "17", "author": "ME Cela", "year": "1996", "unstructured": "Cela ME, Holladay MS, Rooney CM, et al. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors. Bone Marrow Transplant 1996; 17: 243\u2013247.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR192", "doi-asserted-by": "publisher", "first-page": "1069", "DOI": "10.1038/sj.bmt.1700807", "volume": "19", "author": "Y Kawanishi", "year": "1997", "unstructured": "Kawanishi Y, Passweg J, Drobyski WR, et al. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1069\u20131077.", "journal-title": "Bone Marrow Transplant"}, {"key": "25_CR193", "first-page": "205", "volume": "7", "author": "J Norton", "year": "1991", "unstructured": "Norton J, al-Saffar N, Sloane JP. An immunohistological study of gamma/delta lymphocytes in human cutaneous graft-versus-host disease. Bone Marrow Transplant 1991; 7: 205\u2013208.", "journal-title": "Bone Marrow Transplant"}, {"issue": "1027", "key": "25_CR194", "first-page": "1028", "volume": "45", "author": "J Norton", "year": "1992", "unstructured": "Norton J, al-Saffar N, Sloane JP. Immunohistological study of distribution of gamma/delta lymphocytes after allogeneic bone marrow transplantation. J Clin Pathol 1992; 45: 1027, 1028.", "journal-title": "J Clin Pathol"}, {"key": "25_CR195", "first-page": "827", "volume": "87", "author": "BR Blazar", "year": "1996", "unstructured": "Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Barrett TA, Bluestone JA, Vallera DA. Lethal murine graftversus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens. Blood 1996; 87: 827\u2013837.", "journal-title": "Blood"}, {"key": "25_CR196", "first-page": "4189", "volume": "155", "author": "CA Ellison", "year": "1995", "unstructured": "Ellison CA, MacDonald GC, Rector ES, Gartner JG. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. Jlmmunol 1995; 155: 4189\u20134198.", "journal-title": "Jlmmunol"}, {"key": "25_CR197", "doi-asserted-by": "publisher", "first-page": "87", "DOI": "10.1002/eji.1830250117", "volume": "25", "author": "T Sakai", "year": "1995", "unstructured": "Sakai T, Ohara-Inagaki K, Tsuzuki T, Yoshikai Y. Host intestinal intraepithelial gamma delta T lymphocytes present during acute graft-versus-host disease in mice may contribute to the development of enteropathy. Eur Jlmmunol 1995; 25: 87\u201391.", "journal-title": "Eur Jlmmunol"}, {"key": "25_CR198", "first-page": "1100", "volume": "89", "author": "WR Drobyski", "year": "1997", "unstructured": "Drobyski WR, Majewski D. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. Blood 1997; 89: 1100\u20131109.", "journal-title": "Blood"}, {"key": "25_CR199", "doi-asserted-by": "publisher", "first-page": "222", "DOI": "10.1053/bbmt.1999.v5.pm10465102", "volume": "5", "author": "WR Drobyski", "year": "1999", "unstructured": "Drobyski WR, Majewski D, Hanson G. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Biol Blood Marrow Transplant 1999; 5: 222\u2013230.", "journal-title": "Biol Blood Marrow Transplant"}, {"key": "25_CR200", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/S0753-3322(98)80092-9", "volume": "52", "author": "M Nagai", "year": "1998", "unstructured": "Nagai M, Azuma E, Qi J, et al. Suppression of alloreactivity with gamma delta T-cells: relevance to increased gamma delta T-cells following bone marrow transplantation. Biomed Pharmacother 1998; 52: 137\u2013142.", "journal-title": "Biomed Pharmacother"}, {"key": "25_CR201", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1089/scd.1.1996.5.503", "volume": "5", "author": "LS Lamb Jr.", "year": "1996", "unstructured": "Lamb LS, Jr., Henslee-Downey PJ, Parrish RS, et al. Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. J Hematother 1996; 5: 503\u2013509.", "journal-title": "J Hematother"}, {"key": "25_CR202", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.1016/S0167-5699(00)01673-X", "volume": "21", "author": "L Moretta", "year": "2000", "unstructured": "Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A. Human NK-cell receptors. Immunol Today 2000; 21: 420\u2013422.", "journal-title": "Immunol Today"}, {"key": "25_CR203", "doi-asserted-by": "publisher", "first-page": "1626", "DOI": "10.1097/00007890-199912150-00002", "volume": "68", "author": "NT Young", "year": "1999", "unstructured": "Young NT. Kir genes, killer cells and clinical transplantation. Transplantation 1999; 68: 1626\u20131628.", "journal-title": "Transplantation"}, {"key": "25_CR204", "unstructured": "Long E, Colonna M, Lanier L. Protein Reviews On The Web (PROW). KIR. [National Cancer Institute and National Center for Biotechnology Information]. Available at: \n                    http://www.ncbi.nlm.nih.gov\n                    \n                  . Accessed June 2, 2001."}], "container-title": ["Allogeneic Stem Cell Transplantation"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-59259-333-0_25", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 12]], "date-time": "2019-05-12T10:40:45Z", "timestamp": 1557657645000}, "score": 35.218513, "issued": {"date-parts": [[2003]]}, "ISBN": ["9781475744811", "9781592593330"], "references-count": 204, "URL": "http://dx.doi.org/10.1007/978-1-59259-333-0_25", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:10:23Z", "timestamp": 1574269823517}, "reference-count": 25, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 1, 29]], "date-time": "2007-01-29T00:00:00Z", "timestamp": 1170028800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bone Marrow Transplant"], "published-print": {"date-parts": [[2007, 3]]}, "DOI": "10.1038/sj.bmt.1705592", "type": "journal-article", "created": {"date-parts": [[2007, 2, 2]], "date-time": "2007-02-02T18:30:21Z", "timestamp": 1170441021000}, "page": "301-306", "source": "Crossref", "is-referenced-by-count": 40, "title": ["High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation"], "prefix": "10.1038", "volume": "39", "author": [{"given": "J", "family": "El-Cheikh", "sequence": "first", "affiliation": []}, {"given": "C", "family": "Faucher", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "F\u00fcrst", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Duran", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Berger", "sequence": "additional", "affiliation": []}, {"given": "N", "family": "Vey", "sequence": "additional", "affiliation": []}, {"given": "A-M", "family": "Stoppa", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Bouabdallah", "sequence": "additional", "affiliation": []}, {"given": "J-A", "family": "Gastaut", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Viens", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Blaise", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Mohty", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 1, 29]]}, "reference": [{"key": "BF1705592_CR1", "doi-asserted-by": "publisher", "first-page": "470", "DOI": "10.1182/blood-2002-12-3629", "volume": "102", "author": "M Mohty", "year": "2003", "unstructured": "Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood 2003; 102: 470\u2013476.", "journal-title": "Blood"}, {"key": "BF1705592_CR2", "doi-asserted-by": "publisher", "first-page": "756", "DOI": "10.1182/blood-2002-08-2628", "volume": "102", "author": "M Mielcarek", "year": "2003", "unstructured": "Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756\u2013762.", "journal-title": "Blood"}, {"key": "BF1705592_CR3", "doi-asserted-by": "publisher", "first-page": "801", "DOI": "10.1038/sj.bmt.1700737", "volume": "19", "author": "E Jantunen", "year": "1997", "unstructured": "Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801\u2013808.", "journal-title": "Bone Marrow Transplant"}, {"key": "BF1705592_CR4", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1046/j.1365-2141.2002.03259.x", "volume": "116", "author": "R Martino", "year": "2002", "unstructured": "Martino R, Subira M, Rovira M, Solano C, Vazquez L, Sanz GF et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002; 116: 475\u2013482.", "journal-title": "Br J Haematol"}, {"key": "BF1705592_CR5", "doi-asserted-by": "publisher", "first-page": "2168", "DOI": "10.1038/sj.leu.2403105", "volume": "17", "author": "M Mohty", "year": "2003", "unstructured": "Mohty M, Jacot W, Faucher C, Bay JO, Zandotti C, Collet L et al. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia 2003; 17: 2168\u20132177.", "journal-title": "Leukemia"}, {"key": "BF1705592_CR6", "doi-asserted-by": "publisher", "first-page": "827", "DOI": "10.1182/blood-2003-02-0456", "volume": "102", "author": "T Fukuda", "year": "2003", "unstructured": "Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827\u2013833.", "journal-title": "Blood"}, {"key": "BF1705592_CR7", "doi-asserted-by": "publisher", "first-page": "3487", "DOI": "10.1128/AAC.45.12.3487-3496.2001", "volume": "45", "author": "TJ Walsh", "year": "2001", "unstructured": "Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother 2001; 45: 3487\u20133496.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "BF1705592_CR8", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1086/323335", "volume": "34", "author": "S Ascioglu", "year": "2002", "unstructured": "Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7\u201314.", "journal-title": "Clin Infect Dis"}, {"key": "BF1705592_CR9", "doi-asserted-by": "publisher", "first-page": "250", "DOI": "10.1086/515129", "volume": "28", "author": "F Menichetti", "year": "1999", "unstructured": "Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Clin Infect Dis 1999; 28: 250\u2013255.", "journal-title": "Clin Infect Dis"}, {"key": "BF1705592_CR10", "doi-asserted-by": "publisher", "first-page": "705", "DOI": "10.7326/0003-4819-138-9-200305060-00006", "volume": "138", "author": "DJ Winston", "year": "2003", "unstructured": "Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 2003; 138: 705\u2013713.", "journal-title": "Ann Intern Med"}, {"key": "BF1705592_CR11", "doi-asserted-by": "publisher", "first-page": "1527", "DOI": "10.1182/blood-2003-08-2644", "volume": "103", "author": "KA Marr", "year": "2004", "unstructured": "Marr KA, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee SA et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004; 103: 1527\u20131533.", "journal-title": "Blood"}, {"key": "BF1705592_CR12", "doi-asserted-by": "publisher", "first-page": "2099", "DOI": "10.1002/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N", "volume": "73", "author": "GP Bodey", "year": "1994", "unstructured": "Bodey GP, Anaissie EJ, Elting LS, Estey E, O'Brien S, Kantarjian H . Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B. Cancer 1994; 73: 2099\u20132106.", "journal-title": "Cancer"}, {"key": "BF1705592_CR13", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.2165/00003495-199244010-00002", "volume": "44", "author": "CA Lyman", "year": "1992", "unstructured": "Lyman CA, Walsh TJ . Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Drugs 1992; 44: 9\u201335.", "journal-title": "Drugs"}, {"key": "BF1705592_CR14", "doi-asserted-by": "publisher", "first-page": "e29", "DOI": "10.1086/505969", "volume": "43", "author": "AJ Ullmann", "year": "2006", "unstructured": "Ullmann AJ, Sanz MA, Tramarin A, Barnes RA, Wu W, Gerlach BA et al. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries. Clin Infect Dis 2006; 43: e29\u2013e38.", "journal-title": "Clin Infect Dis"}, {"key": "BF1705592_CR15", "doi-asserted-by": "publisher", "first-page": "1694", "DOI": "10.1023/A:1018997730462", "volume": "16", "author": "I Bekersky", "year": "1999", "unstructured": "Bekersky I, Boswell GW, Hiles R, Fielding RM, Buell D, Walsh TJ . Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs. Pharm Res 1999; 16: 1694\u20131701.", "journal-title": "Pharm Res"}, {"key": "BF1705592_CR16", "doi-asserted-by": "publisher", "first-page": "764", "DOI": "10.1056/NEJM199903113401004", "volume": "340", "author": "TJ Walsh", "year": "1999", "unstructured": "Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340: 764\u2013771.", "journal-title": "N Engl J Med"}, {"key": "BF1705592_CR17", "doi-asserted-by": "publisher", "first-page": "1494", "DOI": "10.1023/A:1007605024942", "volume": "17", "author": "I Bekersky", "year": "2000", "unstructured": "Bekersky I, Boswell GW, Hiles R, Fielding RM, Buell D, Walsh TJ . Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats. Pharm Res 2000; 17: 1494\u20131502.", "journal-title": "Pharm Res"}, {"key": "BF1705592_CR18", "first-page": "263", "volume": "42", "author": "GW Boswell", "year": "1998", "unstructured": "Boswell GW, Bekersky I, Buell D, Hiles R, Walsh TJ . Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats. Antimicrob Agents Chemother 1998; 42: 263\u2013268.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "BF1705592_CR19", "doi-asserted-by": "publisher", "first-page": "713", "DOI": "10.1128/AAC.38.4.713", "volume": "38", "author": "JW Lee", "year": "1994", "unstructured": "Lee JW, Amantea MA, Francis PA, Navarro EE, Bacher J, Pizzo PA et al. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother 1994; 38: 713\u2013718.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "BF1705592_CR20", "doi-asserted-by": "publisher", "first-page": "2327", "DOI": "10.1128/AAC.44.9.2327-2332.2000", "volume": "44", "author": "A Garcia", "year": "2000", "unstructured": "Garcia A, Adler-Moore JP, Proffitt RT . Single-dose AmBisome (liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis. Antimicrob Agents Chemother 2000; 44: 2327\u20132332.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "Suppl B", "key": "BF1705592_CR21", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1093/jac/28.suppl_B.49", "volume": "28", "author": "RT Proffitt", "year": "1991", "unstructured": "Proffitt RT, Satorius A, Chiang SM, Sullivan L, Adler-Moore JP . Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 1991; 28 (Suppl B): 49\u201361.", "journal-title": "J Antimicrob Chemother"}, {"key": "BF1705592_CR22", "first-page": "242", "volume": "22", "author": "J Tollemar", "year": "1990", "unstructured": "Tollemar J, Ericzon BG, Holmberg K, Andersson J . The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplant Proc 1990; 22: 242\u2013244.", "journal-title": "Transplant Proc"}, {"key": "BF1705592_CR23", "doi-asserted-by": "publisher", "first-page": "1306", "DOI": "10.1093/annonc/mdl128", "volume": "17", "author": "O Penack", "year": "2006", "unstructured": "Penack O, Schwartz S, Martus P, Reinwald M, Schmidt-Hieber M, Thiel E et al. Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. Ann Oncol 2006; 17: 1306\u20131312.", "journal-title": "Ann Oncol"}, {"key": "BF1705592_CR24", "doi-asserted-by": "publisher", "first-page": "2391", "DOI": "10.1128/AAC.42.9.2391", "volume": "42", "author": "TJ Walsh", "year": "1998", "unstructured": "Walsh TJ, Yeldandi V, McEvoy M, Gonzalez C, Chanock S, Freifeld A et al. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother 1998; 42: 2391\u20132398.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "BF1705592_CR25", "first-page": "1053", "volume": "18", "author": "MD Johnson", "year": "1998", "unstructured": "Johnson MD, Drew RH, Perfect JR . Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature. Pharmacotherapy 1998; 18: 1053\u20131061.", "journal-title": "Pharmacotherapy"}], "container-title": ["Bone Marrow Transplantation"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1705592.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1705592", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1705592.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T12:09:20Z", "timestamp": 1556798960000}, "score": 34.82708, "issued": {"date-parts": [[2007, 1, 29]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2007, 3]]}, "issue": "5"}, "alternative-id": ["BF1705592"], "URL": "http://dx.doi.org/10.1038/sj.bmt.1705592", "relation": {"cites": []}, "ISSN": ["0268-3369", "1476-5365"], "issn-type": [{"value": "0268-3369", "type": "print"}, {"value": "1476-5365", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:01:10Z", "timestamp": 1574506870590}, "reference-count": 7, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 10, 1]], "date-time": "2012-10-01T00:00:00Z", "timestamp": 1349049600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transplantation Proceedings"], "published-print": {"date-parts": [[2012, 10]]}, "DOI": "10.1016/j.transproceed.2012.07.042", "type": "journal-article", "created": {"date-parts": [[2012, 9, 29]], "date-time": "2012-09-29T07:49:30Z", "timestamp": 1348904970000}, "page": "2501-2502", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Case Report of Hepatic Mucormycosis After Liver Transplantation: Successful Treatment With Liposomal Amphotericin B Followed by Posaconazole Sequential Therapy"], "prefix": "10.1016", "volume": "44", "author": [{"given": "C.S.", "family": "Abboud", "sequence": "first", "affiliation": []}, {"given": "M.D.", "family": "Bergamasco", "sequence": "additional", "affiliation": []}, {"given": "C.E.S.", "family": "Ba\u00eda", "sequence": "additional", "affiliation": []}, {"given": "M.P.", "family": "Lall\u00e9e", "sequence": "additional", "affiliation": []}, {"given": "A.S.C.", "family": "Zan", "sequence": "additional", "affiliation": []}, {"given": "M.M.", "family": "Zamorano", "sequence": "additional", "affiliation": []}, {"given": "O.I.", "family": "Pereira", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Mies", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Transplantation Proceedings"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0041134512007385?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0041134512007385?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T12:23:35Z", "timestamp": 1542716615000}, "score": 34.186913, "issued": {"date-parts": [[2012, 10]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[2012, 10]]}, "issue": "8"}, "alternative-id": ["S0041134512007385"], "URL": "http://dx.doi.org/10.1016/j.transproceed.2012.07.042", "ISSN": ["0041-1345"], "issn-type": [{"value": "0041-1345", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T18:59:16Z", "timestamp": 1575140356365}, "reference-count": 10, "publisher": "Springer Science and Business Media LLC", "issue": "10", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1993, 10, 1]], "date-time": "1993-10-01T00:00:00Z", "timestamp": 749433600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Cancer Res Clin Oncol"], "published-print": {"date-parts": [[1993, 10]]}, "DOI": "10.1007/bf01372718", "type": "journal-article", "created": {"date-parts": [[2005, 4, 1]], "date-time": "2005-04-01T22:43:56Z", "timestamp": 1112395436000}, "page": "569-571", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report"], "prefix": "10.1007", "volume": "119", "author": [{"given": "P. C.", "family": "Gokhale", "sequence": "first", "affiliation": []}, {"given": "R. J.", "family": "Barapatre", "sequence": "additional", "affiliation": []}, {"given": "S. H.", "family": "Advani", "sequence": "additional", "affiliation": []}, {"given": "N. A.", "family": "Kshirsagar", "sequence": "additional", "affiliation": []}, {"given": "S. K.", "family": "Pandya", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "CR1", "first-page": "13", "volume": "77", "author": "GP Bodey", "year": "1984", "unstructured": "Bodey GP (1984) Candidiasis in cancer patients. Am J Med 77:13?19", "journal-title": "Am J Med"}, {"key": "CR2", "first-page": "75", "volume": "98", "author": "PC Gokhale", "year": "1993", "unstructured": "Gokhale PC, Kotwani RN, Dange SY, Kshirsagar NA, Pandya SK (1993) Preclinical and pharmaceutical testing of liposomal amphotericin B. Ind J Med Res 98:75?79", "journal-title": "Ind J Med Res"}, {"key": "CR3", "unstructured": "Gokhale PC, Barapatre RJ, Advani SH, Kshirsagar NA, Pandya SK (1993) Pharmacokinetics and tolerability of liposomal amphotericin B in patients. J Antimicrob Chemother (in press)", "DOI": "10.1093/jac/32.1.133", "doi-asserted-by": "crossref"}, {"key": "CR4", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/0002-9343(87)90492-X", "volume": "83", "author": "E Haron", "year": "1987", "unstructured": "Haron E, Feld R, Ruffnell P, Patterson B, Hasselback R, Matlow A (1987) Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med 83:17?26", "journal-title": "Am J Med"}, {"key": "CR5", "first-page": "599", "volume": "13", "author": "C Hawkins", "year": "1984", "unstructured": "Hawkins C, Armstrong D (1984) Fungal infections in the immunocompromised host. Clin Haematol 13:599?630", "journal-title": "Clin Haematol"}, {"key": "CR6", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1093/infdis/151.4.704", "volume": "151", "author": "G Lopez-Berestein", "year": "1985", "unstructured": "Lopez-Berestein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, Rosenblum MG, Mehta R, Luna M, Hersh EM, Reuben J, Juliano RL, Bodey GP (1985) Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 151:704?710", "journal-title": "J Infect Dis"}, {"key": "CR7", "first-page": "177", "volume": "14", "author": "MS Maddux", "year": "1980", "unstructured": "Maddux MS, Barriere SL (1980) A review of complications and amphotericin B therapy: recommendations for prevention and management. Drug Intel Clin Pharm 14:177?181", "journal-title": "Drug Intel Clin Pharm"}, {"issue": "Suppl B", "key": "CR8", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1093/jac/28.suppl_B.73", "volume": "28", "author": "O Ringden", "year": "1991", "unstructured": "Ringden O, Meunier F, Tollemar J, Ricci P, Tura S, Kuse E, Viviani MA, Gorin NC, Klastersky J, Fenaux P, Prentice HG, Ksionski G (1991) Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 28 [Suppl B]:73?82", "journal-title": "J Antimicrob Chemother"}, {"key": "CR9", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.1016/S0277-5379(98)90033-5", "volume": "24", "author": "JP Sculier", "year": "1988", "unstructured": "Sculier JP, Coune A, Meunier F, Brassinne C, Laduron C, Hollaert C, Collette N, Heymans C, Klastersky J (1988) Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. Eur J Cancer Clin Oncol 24:527?538", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "CR10", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1148/radiology.159.2.3961167", "volume": "9", "author": "A Shirkhoda", "year": "1986", "unstructured": "Shirkhoda A, Lopez-Berestein G, Holbert JM, Luna MA (1986) Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. Radiology 9:349?353", "journal-title": "Radiology"}], "container-title": ["Journal of Cancer Research and Clinical Oncology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF01372718.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF01372718/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF01372718", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 2]], "date-time": "2019-05-02T15:16:03Z", "timestamp": 1556810163000}, "score": 34.070473, "issued": {"date-parts": [[1993, 10]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1993, 10]]}, "issue": "10"}, "alternative-id": ["BF01372718"], "URL": "http://dx.doi.org/10.1007/bf01372718", "relation": {"cites": []}, "ISSN": ["0171-5216", "1432-1335"], "issn-type": [{"value": "0171-5216", "type": "print"}, {"value": "1432-1335", "type": "electronic"}], "subject": ["Cancer Research", "Oncology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:07:40Z", "timestamp": 1574276860044}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 2, 1]], "date-time": "2009-02-01T00:00:00Z", "timestamp": 1233446400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2015, 4, 10]], "date-time": "2015-04-10T00:00:00Z", "timestamp": 1428624000000}, "delay-in-days": 2259, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biology of Blood and Marrow Transplantation"], "published-print": {"date-parts": [[2009, 2]]}, "DOI": "10.1016/j.bbmt.2008.12.180", "type": "journal-article", "created": {"date-parts": [[2009, 1, 23]], "date-time": "2009-01-23T10:11:59Z", "timestamp": 1232705519000}, "page": "58", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Combined Risk-Factor Analysis Predicts Outcome of AML Patients After Allogeneic Stem Cell Transplantation Following Reduced Intensity Conditioning"], "prefix": "10.1016", "volume": "15", "author": [{"given": "P.G.", "family": "Hemmati", "sequence": "first", "affiliation": []}, {"given": "T.H.", "family": "Terwey", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Massenkeil", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "le Coutre", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Neuburger", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Dorken", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Arnold", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biology of Blood and Marrow Transplantation"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1083879108007702?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1083879108007702?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 22]], "date-time": "2018-12-22T08:59:29Z", "timestamp": 1545469169000}, "score": 33.554104, "issued": {"date-parts": [[2009, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 2]]}, "issue": "2"}, "alternative-id": ["S1083879108007702"], "URL": "http://dx.doi.org/10.1016/j.bbmt.2008.12.180", "ISSN": ["1083-8791"], "issn-type": [{"value": "1083-8791", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:47:49Z", "timestamp": 1574754469888}, "publisher-location": "Chichester, UK", "reference-count": 144, "publisher": "John Wiley & Sons, Ltd", "isbn-type": [{"value": "9781118416006", "type": "print"}, {"value": "9781118416426", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118416426.ch11", "type": "book-chapter", "created": {"date-parts": [[2016, 1, 2]], "date-time": "2016-01-02T17:47:59Z", "timestamp": 1451756879000}, "page": "126-138", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Natural Killer Cells and Allogeneic Hematopoietic Cell Transplantation"], "prefix": "10.1002", "author": [{"given": "Michael R.", "family": "Verneris", "sequence": "first", "affiliation": []}, {"given": "Jeffrey S.", "family": "Miller", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 1, 1]]}, "reference": [{"key": "10.1002/9781118416426.ch11-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/j.jaci.2013.07.020", "article-title": "Natural killer cell deficiency", "volume": "132", "author": "Orange", "year": "2013", "journal-title": "J Allergy Clin Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1016/S1471-4906(01)02060-9", "article-title": "The biology of human natural killer-cell subsets", "volume": "22", "author": "Cooper", "year": "2001", "journal-title": "Trends Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1084/jem.171.5.1509", "article-title": "Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors", "volume": "171", "author": "Caligiuri", "year": "1990", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB4|cit4", "first-page": "3183", "article-title": "Comparative studies of human FcRIII-positive and negative natural killer cells", "volume": "143", "author": "Nagler", "year": "1989", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/eji.1830220102", "article-title": "Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells", "volume": "22", "author": "Baume", "year": "1992", "journal-title": "Eur J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB6|cit6", "first-page": "4511", "article-title": "Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response", "volume": "162", "author": "Fehniger", "year": "1999", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "3121", "DOI": "10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4", "article-title": "CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells", "volume": "31", "author": "Jacobs", "year": "2001", "journal-title": "Eur J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1158/1078-0432.CCR-11-2277", "article-title": "Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma", "volume": "18", "author": "Pahl", "year": "2012", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9781118416426.ch11-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "e326", "DOI": "10.1371/journal.pone.0000326", "article-title": "Serial killing of tumor cells by human natural killer cells - enhancement by therapeutic antibodies", "volume": "2", "author": "Bhat", "year": "2007", "journal-title": "PLoS One"}, {"key": "10.1002/9781118416426.ch11-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1533", "DOI": "10.1016/S0301-472X(99)00089-2", "article-title": "Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu", "volume": "27", "author": "Cooley", "year": "1999", "journal-title": "Exp Hematol"}, {"key": "10.1002/9781118416426.ch11-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "14151", "DOI": "10.1073/pnas.1835830100", "article-title": "The mature activating natural killer cell immunologic synapse is formed in distinct stages", "volume": "100", "author": "Orange", "year": "2003", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118416426.ch11-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1016/j.molimm.2004.07.034", "article-title": "Activation of NK cell cytotoxicity", "volume": "42", "author": "Smyth", "year": "2005", "journal-title": "Mol Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1111/j.1749-6632.2000.tb05598.x", "article-title": "The complexity of TNF-related apoptosis-inducing ligand", "volume": "926", "author": "Abe", "year": "2000", "journal-title": "Ann N Y Acad Sci"}, {"key": "10.1002/9781118416426.ch11-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1038/sj.leu.2402131", "article-title": "In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity", "volume": "15", "author": "Wuchter", "year": "2001", "journal-title": "Leukemia"}, {"key": "10.1002/9781118416426.ch11-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1016/j.leukres.2003.08.015", "article-title": "Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia", "volume": "28", "author": "Min", "year": "2004", "journal-title": "Leuk Res"}, {"key": "10.1002/9781118416426.ch11-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "3058", "DOI": "10.1182/blood.V98.10.3058", "article-title": "Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis", "volume": "98", "author": "Zang", "year": "2001", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1745", "DOI": "10.1084/jem.162.6.1745", "article-title": "Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism", "volume": "162", "author": "Ljunggren", "year": "1985", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1146/annurev.iy.11.040193.003145", "article-title": "The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex", "volume": "11", "author": "Yokoyama", "year": "1993", "journal-title": "Annu Rev Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "626", "DOI": "10.1016/j.coi.2004.07.010", "article-title": "Killer immunoglobulin-like receptors", "volume": "16", "author": "Moretta", "year": "2004", "journal-title": "Curr Opin Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1038/nri1570", "article-title": "MHC class I molecules and KIRs in human history, health and survival", "volume": "5", "author": "Parham", "year": "2005", "journal-title": "Nat Rev Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1146/annurev.immunol.16.1.359", "article-title": "NK cell receptors", "volume": "16", "author": "Lanier", "year": "1998", "journal-title": "Annu Rev Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1016/S1074-7613(00)80276-9", "article-title": "Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation", "volume": "5", "author": "Binstadt", "year": "1996", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "4539", "DOI": "10.4049/jimmunol.170.9.4539", "article-title": "Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells", "volume": "170", "author": "Yusa", "year": "2003", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1038/35642", "article-title": "Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells", "volume": "391", "author": "Lanier", "year": "1998", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1034/j.1399-0039.2003.00072.x", "article-title": "Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002", "volume": "62", "author": "Marsh", "year": "2003", "journal-title": "Tissue Antigens"}, {"key": "10.1002/9781118416426.ch11-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1038/35014520", "article-title": "Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand", "volume": "405", "author": "Boyington", "year": "2000", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1016/S1074-7613(00)80394-5", "article-title": "Human diversity in killer cell inhibitory receptor genes", "volume": "7", "author": "Uhrberg", "year": "1997", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "2307", "DOI": "10.4049/jimmunol.168.5.2307", "article-title": "Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype", "volume": "168", "author": "Shilling", "year": "2002", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "2411", "DOI": "10.1182/blood-2010-05-283051", "article-title": "Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia", "volume": "116", "author": "Cooley", "year": "2010", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "6640", "DOI": "10.4049/jimmunol.171.12.6640", "article-title": "The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1", "volume": "171", "author": "Pando", "year": "2003", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1084/jem.185.4.795", "article-title": "NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor", "volume": "185", "author": "Brooks", "year": "1997", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB32|cit32", "first-page": "305", "article-title": "Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells", "volume": "162", "author": "Brooks", "year": "1999", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1038/35869", "article-title": "HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C", "volume": "391", "author": "Braud", "year": "1998", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "813", "DOI": "10.1084/jem.187.5.813", "article-title": "Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis", "volume": "187", "author": "Borrego", "year": "1998", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1084/jem.173.4.1017", "article-title": "DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells", "volume": "173", "author": "Houchins", "year": "1991", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB36|cit36", "first-page": "3603", "article-title": "Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C", "volume": "158", "author": "Houchins", "year": "1997", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1126/science.285.5428.730", "article-title": "An activating immunoreceptor complex formed by NKG2D and DAP10", "volume": "285", "author": "Wu", "year": "1999", "journal-title": "Science"}, {"key": "10.1002/9781118416426.ch11-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1126/science.285.5428.727", "article-title": "Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA", "volume": "285", "author": "Bauer", "year": "1999", "journal-title": "Science"}, {"key": "10.1002/9781118416426.ch11-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1016/S1074-7613(01)00095-4", "article-title": "ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor", "volume": "14", "author": "Cosman", "year": "2001", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "12445", "DOI": "10.1073/pnas.93.22.12445", "article-title": "Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium", "volume": "93", "author": "Groh", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118416426.ch11-BIB41|cit41", "first-page": "6178", "article-title": "Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity", "volume": "62", "author": "Pende", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118416426.ch11-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "2066", "DOI": "10.1182/blood-2004-09-3548", "article-title": "Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)", "volume": "105", "author": "Pende", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "1186", "DOI": "10.1038/nature03884", "article-title": "The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor", "volume": "436", "author": "Gasser", "year": "2005", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1007/s002510100325", "article-title": "Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family", "volume": "53", "author": "Steinle", "year": "2001", "journal-title": "Immunogenetics"}, {"key": "10.1002/9781118416426.ch11-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "3615", "DOI": "10.1182/blood-2004-07-2585", "article-title": "Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias", "volume": "105", "author": "Nowbakht", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "1389", "DOI": "10.1182/blood-2003-01-0019", "article-title": "Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia", "volume": "102", "author": "Salih", "year": "2003", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "953", "DOI": "10.1084/jem.188.5.953", "article-title": "Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity", "volume": "188", "author": "Pessino", "year": "1998", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1084/jem.190.10.1505", "article-title": "Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells", "volume": "190", "author": "Pende", "year": "1999", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1146/annurev.immunol.19.1.197", "article-title": "Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis", "volume": "19", "author": "Moretta", "year": "2001", "journal-title": "Annu Rev Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "1656", "DOI": "10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1", "article-title": "NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells", "volume": "29", "author": "Sivori", "year": "1999", "journal-title": "Eur J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1016/j.semcancer.2006.07.005", "article-title": "Tumor and viral recognition by natural killer cells receptors", "volume": "16", "author": "Arnon", "year": "2006", "journal-title": "Semin Cancer Biol"}, {"key": "10.1002/9781118416426.ch11-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "2225", "DOI": "10.1128/JVI.80.5.2225-2233.2006", "article-title": "Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors", "volume": "80", "author": "Chisholm", "year": "2006", "journal-title": "J Virol"}, {"key": "10.1002/9781118416426.ch11-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1084/jem.20011149", "article-title": "Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells", "volume": "195", "author": "Ferlazzo", "year": "2002", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB54|cit54", "unstructured": "Strandmann E Simhadri V Tresckow B Tumor cell-derived HLA-B-associated transkript 3 (BAT3) is a ligand for NKp30 and activates NK cells ASH Meeting Abstracts 2006 108"}, {"key": "10.1002/9781118416426.ch11-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/S1074-7613(00)70060-4", "article-title": "DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes", "volume": "4", "author": "Shibuya", "year": "1996", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1084/jem.20030788", "article-title": "Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule", "volume": "198", "author": "Bottino", "year": "2003", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "9180", "DOI": "10.1158/0008-5472.CAN-04-2682", "article-title": "Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction", "volume": "64", "author": "Castriconi", "year": "2004", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118416426.ch11-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1182/blood-2005-04-1351", "article-title": "Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion", "volume": "107", "author": "Bryceson", "year": "2006", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1111/j.1365-2141.2007.06631.x", "article-title": "Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia", "volume": "138", "author": "Pfeiffer", "year": "2007", "journal-title": "Br J Haematol"}, {"key": "10.1002/9781118416426.ch11-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "3122", "DOI": "10.1182/blood-2003-07-2500", "article-title": "Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?", "volume": "103", "author": "Demanet", "year": "2004", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "2002", "DOI": "10.1038/sj.leu.2403525", "article-title": "Identification of natural killer cell receptor phenotypes associated with leukemia", "volume": "18", "author": "Verheyden", "year": "2004", "journal-title": "Leukemia"}, {"key": "10.1002/9781118416426.ch11-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "1437", "DOI": "10.1038/sj.leu.2404279", "article-title": "Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions", "volume": "20", "author": "Verheyden", "year": "2006", "journal-title": "Leukemia"}, {"key": "10.1002/9781118416426.ch11-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1038/ng934", "article-title": "Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS", "volume": "31", "author": "Martin", "year": "2002", "journal-title": "Nat Genet"}, {"key": "10.1002/9781118416426.ch11-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "3666", "DOI": "10.1182/blood-2005-02-0479", "article-title": "The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions", "volume": "106", "author": "Sconocchia", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "2215", "DOI": "10.1038/sj.leu.2403985", "article-title": "Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice", "volume": "19", "author": "Siegler", "year": "2005", "journal-title": "Leukemia"}, {"key": "10.1002/9781118416426.ch11-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "3661", "DOI": "10.1182/blood.V99.10.3661", "article-title": "Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia", "volume": "99", "author": "Costello", "year": "2002", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1182/blood-2005-08-027979", "article-title": "Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction", "volume": "109", "author": "Fauriat", "year": "2007", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB68|cit68", "first-page": "785", "article-title": "Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission", "volume": "90", "author": "Torelli", "year": "2005", "journal-title": "Haematologica"}, {"key": "10.1002/9781118416426.ch11-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.1182/blood-2004-12-4797", "article-title": "Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells", "volume": "106", "author": "Imai", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "2674", "DOI": "10.1158/1535-7163.MCT-12-0692", "article-title": "Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production", "volume": "11", "author": "Gleason", "year": "2012", "journal-title": "Mol Cancer Ther"}, {"key": "10.1002/9781118416426.ch11-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1016/j.leukres.2007.02.020", "article-title": "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis", "volume": "31", "author": "Rohner", "year": "2007", "journal-title": "Leuk Res"}, {"key": "10.1002/9781118416426.ch11-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "2103", "DOI": "10.1038/sj.leu.2404862", "article-title": "Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells", "volume": "21", "author": "Kato", "year": "2007", "journal-title": "Leukemia"}, {"key": "10.1002/9781118416426.ch11-BIB73|cit73", "first-page": "96", "article-title": "Single adult human CD34+/Lin-/CD38- progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells", "volume": "93", "author": "Miller", "year": "1999", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1084/jem.191.5.771", "article-title": "Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice", "volume": "191", "author": "Kennedy", "year": "2000", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1084/jem.193.2.219", "article-title": "Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells", "volume": "193", "author": "Fehniger", "year": "2001", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1182/blood.V98.3.705", "article-title": "Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2", "volume": "98", "author": "Miller", "year": "2001", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1111/j.1600-065X.2006.00451.x", "article-title": "Human natural killer cell development", "volume": "214", "author": "Freud", "year": "2006", "journal-title": "Immunol Rev"}, {"key": "10.1002/9781118416426.ch11-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1084/jem.20052507", "article-title": "Evidence for discrete stages of human natural killer cell differentiation in vivo", "volume": "203", "author": "Freud", "year": "2006", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/j.immuni.2005.01.013", "article-title": "A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells", "volume": "22", "author": "Freud", "year": "2005", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "1367", "DOI": "10.1038/nature08900", "article-title": "Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity", "volume": "464", "author": "Neill", "year": "2010", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1038/ni.1962", "article-title": "The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling", "volume": "12", "author": "Spits", "year": "2011", "journal-title": "Nat Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1146/annurev-immunol-020711-075053", "article-title": "Innate lymphoid cells: emerging insights in development, lineage relationships, and function", "volume": "30", "author": "Spits", "year": "2012", "journal-title": "Annu Rev Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "3451", "DOI": "10.1073/pnas.1201042109", "article-title": "Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice", "volume": "109", "author": "Yasuda", "year": "2012", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118416426.ch11-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1038/nature07537", "article-title": "A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity", "volume": "457", "author": "Cella", "year": "2009", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "4052", "DOI": "10.1182/blood-2010-09-303081", "article-title": "Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue", "volume": "117", "author": "Tang", "year": "2011", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1038/ni1022", "article-title": "An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells", "volume": "5", "author": "Eberl", "year": "2004", "journal-title": "Nat Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1038/nature03847", "article-title": "Licensing of natural killer cells by host major histocompatibility complex class I molecules", "volume": "436", "author": "Kim", "year": "2005", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1111/j.1600-065X.2006.00458.x", "article-title": "Licensing of natural killer cells by self-major histocompatibility complex class I", "volume": "214", "author": "Yokoyama", "year": "2006", "journal-title": "Immunol Rev"}, {"key": "10.1002/9781118416426.ch11-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1182/blood-2006-07-036228", "article-title": "A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature", "volume": "110", "author": "Cooley", "year": "2007", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "3824", "DOI": "10.1182/blood-2006-04-020198", "article-title": "Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells", "volume": "108", "author": "Grzywacz", "year": "2006", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB91|cit91", "doi-asserted-by": "crossref", "first-page": "2073", "DOI": "10.1084/jem.20100986", "article-title": "MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment", "volume": "207", "author": "Elliott", "year": "2010", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB92|cit92", "doi-asserted-by": "crossref", "first-page": "2065", "DOI": "10.1084/jem.20100570", "article-title": "Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment", "volume": "207", "author": "Joncker", "year": "2010", "journal-title": "J Exp Med"}, {"key": "10.1002/9781118416426.ch11-BIB93|cit93", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1038/sj.bmt.1704084", "article-title": "A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors", "volume": "32", "author": "Petersen", "year": "2003", "journal-title": "Bone Marrow Transplant"}, {"key": "10.1002/9781118416426.ch11-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1046/j.1365-2141.2002.03560.x", "article-title": "Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery", "volume": "118", "author": "Kalwak", "year": "2002", "journal-title": "Br J Haematol"}, {"key": "10.1002/9781118416426.ch11-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.1046/j.1365-2141.2001.02934.x", "article-title": "A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors", "volume": "114", "author": "Eyrich", "year": "2001", "journal-title": "Br J Haematol"}, {"key": "10.1002/9781118416426.ch11-BIB96|cit96", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1046/j.1365-2141.2001.02900.x", "article-title": "Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis", "volume": "114", "author": "Niehues", "year": "2001", "journal-title": "Br J Haematol"}, {"key": "10.1002/9781118416426.ch11-BIB97|cit97", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/S0301-472X(00)00667-6", "article-title": "Analysis of immune reconstitution in children undergoing cord blood transplantation", "volume": "29", "author": "Moretta", "year": "2001", "journal-title": "Exp Hematol"}, {"key": "10.1002/9781118416426.ch11-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1038/sj.bmt.1701581", "article-title": "Immune reconstitution following allogeneic peripheral blood stem cell transplants", "volume": "23", "author": "Shenoy", "year": "1999", "journal-title": "Bone Marrow Transplant"}, {"key": "10.1002/9781118416426.ch11-BIB99|cit99", "doi-asserted-by": "crossref", "first-page": "4135", "DOI": "10.1182/blood-2004-10-4113", "article-title": "NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect", "volume": "105", "author": "Nguyen", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "3730", "DOI": "10.1182/blood-2002-08-2568", "article-title": "Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation", "volume": "101", "author": "Shilling", "year": "2003", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB101|cit101", "doi-asserted-by": "crossref", "first-page": "3028", "DOI": "10.1002/eji.200425418", "article-title": "The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity", "volume": "34", "author": "Vitale", "year": "2004", "journal-title": "Eur J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB102|cit102", "doi-asserted-by": "crossref", "first-page": "1530", "DOI": "10.1182/blood-2006-10-048173", "article-title": "The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations", "volume": "110", "author": "Wang", "year": "2007", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB103|cit103", "doi-asserted-by": "crossref", "first-page": "3860", "DOI": "10.1182/blood-2003-04-1200", "article-title": "Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand", "volume": "103", "author": "Chklovskaia", "year": "2004", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB104|cit104", "first-page": "3239", "article-title": "CD16- CD56+ natural killer cells after bone marrow transplantation", "volume": "79", "author": "Jacobs", "year": "1992", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB105|cit105", "doi-asserted-by": "crossref", "first-page": "4370", "DOI": "10.1182/blood-2005-04-1644", "article-title": "KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation", "volume": "106", "author": "Cooley", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB106|cit106", "first-page": "29", "article-title": "The impact of immunosuppressive therapy on an early quantitative NK cell reconstitution after allogeneic haematopoietic cell transplantation", "volume": "10", "author": "Giebel", "year": "2005", "journal-title": "Ann Transplant"}, {"key": "10.1002/9781118416426.ch11-BIB107|cit107", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1182/blood-2004-10-4035", "article-title": "NK-dependent DC maturation is mediated by TNF\u03b1 and IFN\u03b3 released upon engagement of the NKp30 triggering receptor", "volume": "106", "author": "Vitale", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB108|cit108", "doi-asserted-by": "crossref", "first-page": "8662", "DOI": "10.1073/pnas.0503360102", "article-title": "Survival adjustment of mature dendritic cells by IL-15", "volume": "102", "author": "Dubois", "year": "2005", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118416426.ch11-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1016/j.immuni.2007.03.006", "article-title": "Dendritic cells prime natural killer cells by trans-presenting interleukin 15", "volume": "26", "author": "Lucas", "year": "2007", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB110|cit110", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.4049/jimmunol.174.2.727", "article-title": "The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions", "volume": "174", "author": "Gerosa", "year": "2005", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB111|cit111", "doi-asserted-by": "crossref", "first-page": "1590", "DOI": "10.4049/jimmunol.166.3.1590", "article-title": "Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells", "volume": "166", "author": "Yu", "year": "2001", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB112|cit112", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1016/j.jhep.2005.05.026", "article-title": "Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas", "volume": "43", "author": "Jinushi", "year": "2005", "journal-title": "J Hepatol"}, {"key": "10.1002/9781118416426.ch11-BIB113|cit113", "doi-asserted-by": "crossref", "first-page": "2030", "DOI": "10.1182/blood-2005-07-2696", "article-title": "Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction", "volume": "107", "author": "Pende", "year": "2006", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1126/science.285.5426.412", "article-title": "Prevention of graft versus host disease by inactivation of host antigen-presenting cells", "volume": "285", "author": "Shlomchik", "year": "1999", "journal-title": "Science"}, {"key": "10.1002/9781118416426.ch11-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "2097", "DOI": "10.1126/science.1068440", "article-title": "Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants", "volume": "295", "author": "Ruggeri", "year": "2002", "journal-title": "Science"}, {"key": "10.1002/9781118416426.ch11-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "1731", "DOI": "10.1056/NEJM198906293202605", "article-title": "Severe herpesvirus infections in an adolescent without natural killer cells", "volume": "320", "author": "Biron", "year": "1989", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118416426.ch11-BIB117|cit117", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1016/j.jpeds.2004.11.022", "article-title": "Fatal varicella associated with selective natural killer cell deficiency", "volume": "146", "author": "Etzioni", "year": "2005", "journal-title": "J Pediatr"}, {"key": "10.1002/9781118416426.ch11-BIB118|cit118", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1542/peds.113.1.136", "article-title": "A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells", "volume": "113", "author": "Bernard", "year": "2004", "journal-title": "Pediatrics"}, {"key": "10.1002/9781118416426.ch11-BIB119|cit119", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1203/00006450-199510000-00001", "article-title": "X-linked lymphoproliferative disease: twenty-five years after the discovery", "volume": "38", "author": "Seemayer", "year": "1995", "journal-title": "Pediatr Res"}, {"key": "10.1002/9781118416426.ch11-BIB120|cit120", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1038/ng0501-42", "article-title": "Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily", "volume": "28", "author": "Lee", "year": "2001", "journal-title": "Nat Genet"}, {"key": "10.1002/9781118416426.ch11-BIB121|cit121", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1038/nature07665", "article-title": "Adaptive immune features of natural killer cells", "volume": "457", "author": "Sun", "year": "2009", "journal-title": "Nature"}, {"key": "10.1002/9781118416426.ch11-BIB122|cit122", "doi-asserted-by": "crossref", "first-page": "2665", "DOI": "10.1182/blood-2011-10-386995", "article-title": "Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function", "volume": "119", "author": "Foley", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB123|cit123", "doi-asserted-by": "crossref", "first-page": "3051", "DOI": "10.1182/blood-2004-07-2974", "article-title": "Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer", "volume": "105", "author": "Miller", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB124|cit124", "first-page": "333", "article-title": "Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation", "volume": "94", "author": "Ruggeri", "year": "1999", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB125|cit125", "doi-asserted-by": "crossref", "first-page": "1121", "DOI": "10.1126/science.8493555", "article-title": "Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C", "volume": "260", "author": "Colonna", "year": "1993", "journal-title": "Science"}, {"key": "10.1002/9781118416426.ch11-BIB126|cit126", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1182/blood-2006-07-038687", "article-title": "Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value", "volume": "110", "author": "Ruggeri", "year": "2007", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB127|cit127", "doi-asserted-by": "crossref", "first-page": "6540", "DOI": "10.4049/jimmunol.174.10.6540", "article-title": "Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors", "volume": "174", "author": "Leung", "year": "2005", "journal-title": "J Immunol"}, {"key": "10.1002/9781118416426.ch11-BIB128|cit128", "doi-asserted-by": "crossref", "first-page": "1238", "DOI": "10.1182/blood-2005-07-2809", "article-title": "KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia", "volume": "107", "author": "Triplett", "year": "2006", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB129|cit129", "doi-asserted-by": "crossref", "first-page": "3825", "DOI": "10.1182/blood-2002-04-1197", "article-title": "Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor", "volume": "100", "author": "Davies", "year": "2002", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB130|cit130", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1182/blood-2003-01-0091", "article-title": "Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors", "volume": "102", "author": "Giebel", "year": "2003", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB131|cit131", "doi-asserted-by": "crossref", "first-page": "4878", "DOI": "10.1182/blood-2004-12-4825", "article-title": "Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes", "volume": "105", "author": "Hsu", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB132|cit132", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.1097/01.TP.0000137103.19717.86", "article-title": "Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation", "volume": "78", "author": "Schaffer", "year": "2004", "journal-title": "Transplantation"}, {"key": "10.1002/9781118416426.ch11-BIB133|cit133", "doi-asserted-by": "crossref", "first-page": "1024", "DOI": "10.1097/01.tp.0000235859.24513.43", "article-title": "Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation", "volume": "82", "author": "Kroger", "year": "2006", "journal-title": "Transplantation"}, {"key": "10.1002/9781118416426.ch11-BIB134|cit134", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1111/j.1399-0039.2005.00396.x", "article-title": "Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants", "volume": "65", "author": "De Santis", "year": "2005", "journal-title": "Tissue Antigens"}, {"key": "10.1002/9781118416426.ch11-BIB135|cit135", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1016/j.bbmt.2006.05.007", "article-title": "The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry", "volume": "12", "author": "Farag", "year": "2006", "journal-title": "Biol Blood Marrow Transplant"}, {"key": "10.1002/9781118416426.ch11-BIB136|cit136", "doi-asserted-by": "crossref", "first-page": "1446", "DOI": "10.1038/sj.leu.2403839", "article-title": "A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation", "volume": "19", "author": "Verheyden", "year": "2005", "journal-title": "Leukemia"}, {"key": "10.1002/9781118416426.ch11-BIB137|cit137", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1038/sj.bmt.1705468", "article-title": "Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders", "volume": "38", "author": "Chen", "year": "2006", "journal-title": "Bone Marrow Transplant"}, {"key": "10.1002/9781118416426.ch11-BIB138|cit138", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.3109/14653249.2010.515582", "article-title": "A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer", "volume": "13", "author": "Geller", "year": "2011", "journal-title": "Cytotherapy"}, {"key": "10.1002/9781118416426.ch11-BIB139|cit139", "doi-asserted-by": "crossref", "first-page": "3132", "DOI": "10.1182/blood.V97.10.3132", "article-title": "Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo", "volume": "97", "author": "Koh", "year": "2001", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB140|cit140", "doi-asserted-by": "crossref", "first-page": "5460", "DOI": "10.1073/pnas.0509249103", "article-title": "Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells", "volume": "103", "author": "Barao", "year": "2006", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118416426.ch11-BIB141|cit141", "doi-asserted-by": "crossref", "first-page": "1160", "DOI": "10.1016/j.exphem.2005.06.024", "article-title": "KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity", "volume": "33", "author": "Suck", "year": "2005", "journal-title": "Exp Hematol"}, {"key": "10.1002/9781118416426.ch11-BIB142|cit142", "first-page": "1265", "article-title": "Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction", "volume": "100", "author": "Uherek", "year": "2002", "journal-title": "Blood"}, {"key": "10.1002/9781118416426.ch11-BIB143|cit143", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/j.immuni.2006.06.013", "article-title": "Human NK cell education by inhibitory receptors for MHC class I", "volume": "25", "author": "Anfossi", "year": "2006", "journal-title": "Immunity"}, {"key": "10.1002/9781118416426.ch11-BIB144|cit144", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1111/j.1423-0410.2005.00712.x", "article-title": "The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation", "volume": "90", "author": "Witt", "year": "2006", "journal-title": "Vox Sang"}], "container-title": ["Thomas\u2019 Hematopoietic Cell Transplantation"], "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9781118416426.ch11", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 3]], "date-time": "2019-09-03T04:14:58Z", "timestamp": 1567484098000}, "score": 33.50138, "issued": {"date-parts": [[2016, 1, 1]]}, "ISBN": ["9781118416426", "9781118416006"], "references-count": 144, "URL": "http://dx.doi.org/10.1002/9781118416426.ch11", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:39:06Z", "timestamp": 1574159946810}, "reference-count": 7, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bone Marrow Transplant"], "published-print": {"date-parts": [[2003, 4]]}, "DOI": "10.1038/sj.bmt.1703897", "type": "journal-article", "created": {"date-parts": [[2003, 4, 11]], "date-time": "2003-04-11T15:28:15Z", "timestamp": 1050074895000}, "page": "621-622", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Successful remission of chronic, refractory autoimmune thrombocytopenic purpura following non-myeloablative allogeneic stem cell transplantation"], "prefix": "10.1038", "volume": "31", "author": [{"given": "J P", "family": "Butler", "sequence": "first", "affiliation": []}, {"given": "S T S", "family": "Durrant", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Frost", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2003, 4, 11]]}, "reference": [{"key": "BF1703897_CR1", "doi-asserted-by": "publisher", "first-page": "702", "DOI": "10.1136/ard.60.7.702", "volume": "60", "author": "A Tyndall", "year": "2001", "unstructured": "Tyndall A, Passweg J, Gratwohl A . Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000. Ann Rheum Dis 2001; 60: 702\u2013707.", "journal-title": "Ann Rheum Dis"}, {"key": "BF1703897_CR2", "first-page": "31", "volume": "9", "author": "J Yin", "year": "1992", "unstructured": "Yin J, Jowitt S . Resolution of immune-mediated diseases following allogeneic bone marrow transplantation. Br Med J 1992; 9: 31\u201333.", "journal-title": "Br Med J"}, {"key": "BF1703897_CR3", "doi-asserted-by": "publisher", "first-page": "340", "DOI": "10.1097/00007890-200107270-00032", "volume": "72", "author": "S Chakrabarti", "year": "2001", "unstructured": "Chakrabarti S, Handa S, Byron R et al. Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? Transplantation 2001; 72: 340\u2013342.", "journal-title": "Transplantation"}, {"key": "BF1703897_CR4", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1038/sj.bmt.1700924", "volume": "20", "author": "R Martino", "year": "1997", "unstructured": "Martino R, Sureda A, Brunet S . Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report. Bone Marrow Transplant 1997; 20: 521.", "journal-title": "Bone Marrow Transplant"}, {"key": "BF1703897_CR5", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1038/sj.bmt.1700907", "volume": "20", "author": "F Raetz", "year": "1997", "unstructured": "Raetz F, Beatty P, Adams R . Treatment of severe Evan's Syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant 1997; 20: 427\u2013429.", "journal-title": "Bone Marrow Transplant"}, {"key": "BF1703897_CR6", "doi-asserted-by": "publisher", "first-page": "903", "DOI": "10.1038/sj.bmt.1703237", "volume": "28", "author": "Y Oyama", "year": "2001", "unstructured": "Oyama Y, Papadopoulos EB, Miranda M et al. Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant 2001; 28: 903\u2013905.", "journal-title": "Bone Marrow Transplant"}, {"key": "BF1703897_CR7", "first-page": "4609", "volume": "19", "author": "I Sniecinski", "year": "1987", "unstructured": "Sniecinski I, Petz L, Oien L, Blume K . Immuno-hematologic problems arising from ABO incompatible bone marrow transplantation. Transplant Proc 1987; 19: 4609\u20134611.", "journal-title": "Transplant Proc"}], "container-title": ["Bone Marrow Transplantation"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1703897", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1703897.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1703897.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T17:23:43Z", "timestamp": 1547227423000}, "score": 33.379406, "issued": {"date-parts": [[2003, 4]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[2003, 4]]}, "issue": "7"}, "alternative-id": ["BF1703897"], "URL": "http://dx.doi.org/10.1038/sj.bmt.1703897", "relation": {"cites": []}, "ISSN": ["0268-3369", "1476-5365"], "issn-type": [{"value": "0268-3369", "type": "print"}, {"value": "1476-5365", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:05:03Z", "timestamp": 1574172303904}, "reference-count": 0, "publisher": "BMJ", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "published-print": {"date-parts": [[2003, 10, 1]]}, "DOI": "10.1136/gut.52.10.1518", "type": "journal-article", "created": {"date-parts": [[2003, 9, 11]], "date-time": "2003-09-11T17:56:15Z", "timestamp": 1063302975000}, "page": "1518-1521", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Fulminant Crohn's colitis after allogeneic stem cell transplantation"], "prefix": "10.1136", "volume": "52", "author": [{"given": "S A", "family": "Sonwalkar", "sequence": "first", "affiliation": []}], "member": "239", "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.52.10.1518", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T20:46:13Z", "timestamp": 1482525973000}, "score": 33.344162, "issued": {"date-parts": [[2003, 10, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 10, 1]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1136/gut.52.10.1518", "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T08:08:54Z", "timestamp": 1574410134280}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 2, 1]], "date-time": "2010-02-01T00:00:00Z", "timestamp": 1264982400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2015, 4, 10]], "date-time": "2015-04-10T00:00:00Z", "timestamp": 1428624000000}, "delay-in-days": 1894, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biology of Blood and Marrow Transplantation"], "published-print": {"date-parts": [[2010, 2]]}, "DOI": "10.1016/j.bbmt.2009.12.370", "type": "journal-article", "created": {"date-parts": [[2010, 2, 9]], "date-time": "2010-02-09T15:24:48Z", "timestamp": 1265729088000}, "page": "S279", "source": "Crossref", "is-referenced-by-count": 1, "title": ["CD3 Cell Dose And Outcome After Allogeneic Stem Cell Transplantation"], "prefix": "10.1016", "volume": "16", "author": [{"given": "S.", "family": "Farhan", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Mckinnon", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Fortney", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Divine", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Janakiraman", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biology of Blood and Marrow Transplantation"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1083879109009665?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1083879109009665?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 13]], "date-time": "2018-12-13T09:55:48Z", "timestamp": 1544694948000}, "score": 33.026222, "issued": {"date-parts": [[2010, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 2]]}, "issue": "2"}, "alternative-id": ["S1083879109009665"], "URL": "http://dx.doi.org/10.1016/j.bbmt.2009.12.370", "ISSN": ["1083-8791"], "issn-type": [{"value": "1083-8791", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:15:32Z", "timestamp": 1574136932885}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 9, 1]], "date-time": "1999-09-01T00:00:00Z", "timestamp": 936144000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[1999, 9]]}, "DOI": "10.1016/s0959-8049(99)81611-6", "type": "journal-article", "created": {"date-parts": [[2002, 10, 16]], "date-time": "2002-10-16T14:35:53Z", "timestamp": 1034778953000}, "page": "S296", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Treatment of documented deep fungal infections in patients with sibling or unrelated stem cell transplantation: a study comparing safety and efficacy of conventional amphotericin B to liposomal amphotericin B (ambisome\u00ae)"], "prefix": "10.1016", "volume": "35", "author": [{"given": "A.A.", "family": "Fauser", "sequence": "first", "affiliation": []}, {"given": "I.W.", "family": "Blau", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Basara", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Rudolphi", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Roemer", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Bischoff", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "G\u00fcnzelmann", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Kirsten", "sequence": "additional", "affiliation": []}, {"given": "M.G.", "family": "Kiehl", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804999816116?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804999816116?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T05:57:53Z", "timestamp": 1554703073000}, "score": 32.980488, "issued": {"date-parts": [[1999, 9]]}, "references-count": 0, "alternative-id": ["S0959804999816116"], "URL": "http://dx.doi.org/10.1016/s0959-8049(99)81611-6", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:14:47Z", "timestamp": 1574468087450}, "reference-count": 16, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1240, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1111/j.1365-2354.2012.01345.x", "type": "journal-article", "created": {"date-parts": [[2012, 4, 10]], "date-time": "2012-04-10T01:03:30Z", "timestamp": 1334019810000}, "page": "548-559", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Patients' quality of life after allogeneic haematopoietic stem cell transplantation: mixed-methods study"], "prefix": "10.1111", "volume": "21", "author": [{"given": "S.", "family": "NIEDERBACHER", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "THEM", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "PINNA", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "VITTADELLO", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "MANTOVAN", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 4, 9]]}, "reference": [{"key": "10.1111/j.1365-2354.2012.01345.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1200/JCO.2005.03.189", "article-title": "Long-term-health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation", "volume": "23", "author": "Andrykowski", "year": "2005", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "819", "DOI": "10.1038/bmt.2008.253", "article-title": "Quality of life and social integration after allogeneic hematopoietic SCT", "volume": "42", "author": "Bieri", "year": "2008", "journal-title": "Bone Marrow Transplantation"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB3|cit3", "author": "Burns", "year": "2005", "volume-title": "Pflegeforschung verstehen und anwenden"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1111/j.1365-2702.2009.02896.x", "article-title": "Translation and back-translation in qualitative nursing research: methodological review", "volume": "19", "author": "Chen", "year": "2009", "journal-title": "Journal of Clinical Nursing"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1111/j.1365-2354.2008.00931.x", "article-title": "Health psychology and distress after haematopoietic stem cell transplantation", "volume": "18", "author": "De Marinis", "year": "2009", "journal-title": "European Journal of Cancer Care"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1046/j.1365-2354.2001.00251.x", "article-title": "Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell-transplantation", "volume": "10", "author": "Edman", "year": "2001", "journal-title": "European Journal of Cancer Care"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB7|cit7", "author": "Faller", "year": "1998", "volume-title": "Positive und negative Effekte sozialer Unterst\u00fctzung bei Krebspatienten"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB8|cit8", "first-page": "249", "article-title": "The long-term psychosocial effects of haematopoetic stem cell transplantation", "volume": "12", "author": "Gruber", "year": "2003", "journal-title": "European Journal of Cancer Care"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1007/s002770000249", "article-title": "Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation", "volume": "80", "author": "Heinonen", "year": "2001", "journal-title": "Annals of Hematology"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1034/j.1600-0609.2000.90143.x", "article-title": "EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison", "volume": "65", "author": "Kopp", "year": "2000", "journal-title": "European Journal of Haematology"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB12|cit11", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.1053/bbmt.2002.v8.pm12234170", "article-title": "Development and validation of a scale to measure symptoms of chronic graft-versus-host disease", "volume": "8", "author": "Lee", "year": "2002", "journal-title": "Biology of Blood and Marrow Transplantation"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB11|cit12", "doi-asserted-by": "crossref", "first-page": "2194", "DOI": "10.1182/blood-2003-07-2430", "article-title": "Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation", "volume": "104", "author": "Lee", "year": "2004", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB13|cit13", "author": "Mayring", "year": "2002", "volume-title": "Einf\u00fchrung in die qualitative Sozialforschung"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1038/sj.bmt.1700672", "article-title": "Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale", "volume": "19", "author": "McQuellon", "year": "1997", "journal-title": "Bone Marrow Transplantation"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1182/blood-2008-10-182592", "article-title": "Quality of life after allogeneic hematopoietic cell transplantation", "volume": "114", "author": "Pidala", "year": "2009", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2354.2012.01345.x-BIB16|cit16", "first-page": "41", "article-title": "Understanding physicians' skills at providing end-of-life care - perspective of patients, families and health care workers", "volume": "16", "author": "Randall Curtis", "year": "2001", "journal-title": "Journal of General Internal Medicine"}], "container-title": ["European Journal of Cancer Care"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2354.2012.01345.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T17:03:28Z", "timestamp": 1497978208000}, "score": 32.962696, "subtitle": ["QOL after allogeneic HSCT"], "issued": {"date-parts": [[2012, 4, 9]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2012, 7]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/j.1365-2354.2012.01345.x", "relation": {"cites": []}, "ISSN": ["0961-5423"], "issn-type": [{"value": "0961-5423", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}